≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

Poisoning by medicine, drug-induced

Endpoint Browser

ST19_POISO_MEDICI_ADVERSE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ATC codes for adverse effects of Drugs — ANY
  • Hospital discharge: ICD-10 — T36#

1 out of 7 registries used, show all original rules.

501

4. Check minimum number of events

None

501

5. Include endpoints

None

501

6. Filter based on genotype QC (FinnGen only)

476

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF5
Parent code in ICD-10
T3[6-9]|T4|T50
Name in latin
Intoxicatio medicamentosa

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 476 291 185
Unadjusted period prevalence (%) 0.10 0.10 0.08
Median age at first event (years) 34.49 33.93 35.38

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
501
Matched controls
5010
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T36
ICD-10 Finland
Poisoning by systemic antibiotics
+∞
307.7
501
127
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
113.4
307.7
338
90
N05AA02
ATC
levomepromazine; systemic
25.6
233.6
185
112
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
18.9
229.4
227
210
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
17.5
215.4
222
218
N05CD07
ATC
temazepam; oral
16.1
210.0
234
259
N05BA01
ATC
diazepam; systemic, rectal
13.2
191.9
267
399
N05AH03
ATC
olanzapine; systemic
15.4
187.1
202
210
F32.9
ICD-10 Finland
Depressive episode, unspecified
12.3
181.3
266
422
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
45.6
177.6
108
30
N03AG01
ATC
valproic acid; systemic, rectal
13.9
156.5
173
183
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
39.1
155.0
98
31
N05AF03
ATC
chlorprothixene; systemic
22.0
153.8
123
73
N05AH04
ATC
quetiapine; oral
9.8
149.9
296
645
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
28.6
148.9
105
46
N07BB01
ATC
disulfiram; oral
15.1
143.4
144
130
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
12.0
139.8
171
207
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
32.4
138.9
93
35
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
19.2
138.7
118
79
N06AB04
ATC
citalopram; systemic
8.1
124.2
278
669
F10.20
ICD-10 Finland
Alcohol dependence currently independent
22.0
124.0
97
54
N05AA01
ATC
chlorpromazine; systemic, rectal
30.4
123.3
84
33
N05BA04
ATC
oxazepam; oral
8.0
120.9
318
894
N06AB03
ATC
fluoxetine; oral
8.4
118.5
213
405
N05AX08
ATC
risperidone; systemic
10.1
115.0
157
216
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
27.4
112.0
79
34
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
30.8
109.7
74
28
F60.9
ICD-10 Finland
Personality disorder, unspecified
25.9
109.5
79
36
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
34.3
109.2
71
24
F61.0
ICD-10 Finland
Mixed personality disorders
22.3
105.3
81
43
V03AA01, ,
ATC
29.4
103.7
71
28
N06AX03
ATC
mianserin; oral
12.1
101.8
114
119
F29
ICD-10 Finland
Unspecified nonorganic psychosis
12.0
101.2
114
120
F10.25
ICD-10 Finland
Alcohol dependence continuous use
20.1
99.2
80
47
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
10.3
97.8
126
159
N05BE01
ATC
buspirone; oral
13.9
97.8
98
86
N05AX12
ATC
aripiprazole; systemic
11.7
96.2
110
118
N05AD01
ATC
haloperidol; systemic
19.5
95.5
78
47
N05CF01
ATC
zopiclone; oral
6.3
92.9
319
1085
XF400
NOMESCO Finland
ECG with 12 standard connections
7.0
92.5
187
391
N03AX09
ATC
lamotrigine; oral
9.7
89.3
119
156
N03AE01
ATC
clonazepam; systemic
10.3
89.2
112
136
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
14.6
87.7
84
68
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
31.1
86.8
58
21
N05AB03
ATC
perphenazine; systemic, rectal
12.3
86.2
93
91
N06AX11
ATC
mirtazapine; oral
6.1
85.7
336
1257
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
21.8
84.6
65
34
N05AH02
ATC
clozapine; systemic
14.8
80.3
76
60
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
8.7
80.3
117
170
N05AN01
ATC
lithium; oral
13.4
79.5
80
70
N06AB06
ATC
sertraline; oral
6.2
78.7
177
404
N05AB01
ATC
dixyrazine; systemic
33.3
78.2
51
17
R56.8
ICD-10 Finland
Other and unspecified convulsions
10.0
78.0
99
121
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
8.9
76.8
108
150
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
22.5
76.8
58
29
F10.09
ICD-10 Finland
Alcohol intoxication UNS
15.0
73.0
68
52
F20.9
ICD-10 Finland
Schizophrenia, unspecified
13.9
72.6
71
59
N05BA02
ATC
chlordiazepoxide; systemic
13.4
72.1
72
62
N05AD03
ATC
melperone; systemic
29.4
70.7
48
18
N06AB08
ATC
fluvoxamine; oral
12.2
70.7
75
71
N05BA06
ATC
lorazepam; systemic, sublingual
8.9
70.4
97
131
N06AX16
ATC
venlafaxine; oral
5.3
69.5
195
535
N05AC02
ATC
thioridazine; oral
17.1
67.6
58
38
N05AF01
ATC
flupentixol; systemic
20.3
67.3
53
29
N04AA02
ATC
biperiden; systemic
14.2
67.0
64
51
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
6.3
66.5
135
276
F10.24
ICD-10 Finland
Alcohol depence active use
13.7
66.4
65
54
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
18.0
66.0
55
34
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
15.4
65.8
60
44
188
Kela drug reimbursment
Psychosis requiring demanding treatment
26.6
65.5
46
19
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
19.0
61.7
50
29
N05BA12
ATC
alprazolam; oral
5.8
61.3
137
305
N06AB05
ATC
paroxetine; oral
7.3
61.1
101
167
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
15.3
60.5
55
40
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
5.4
59.8
150
369
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
21.0
59.5
46
24
A06AD11
ATC
lactulose; oral
5.6
59.1
136
310
N03AF01
ATC
carbamazepine; oral, rectal
8.2
58.7
86
124
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
20.2
58.5
46
25
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
26.2
58.1
41
17
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
16.9
57.0
49
32
N06AA12
ATC
doxepin; systemic
7.9
56.5
85
126
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
20.4
55.0
43
23
C07AA05
ATC
propranolol; systemic
4.3
53.9
213
742
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
11.6
53.6
58
56
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.3
53.0
129
307
IGY02, ,
SPAT
14.6
52.7
49
37
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
12.0
52.2
55
51
P15
ICPC
Chronic alcohol abuse
8.7
50.1
68
89
X61
ICD-10 Finland
Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified
69.8
49.4
56
9
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
13.2
48.6
48
40
P29
ICPC
Psychological sympt/compl other
5.5
47.9
109
243
N05AF05
ATC
zuclopenthixol; systemic
17.5
46.6
39
24
P99
ICPC
Psychological disorders other
8.5
46.5
64
85
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
16.8
45.6
39
25
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
8.4
45.6
63
84
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
4.6
45.1
130
352
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
13.3
44.1
43
35
N06AG02
ATC
moclobemide; oral
7.3
43.8
69
107
B18.2
ICD-10 Finland
Chronic viral hepatitis C
12.3
43.7
45
40
N06AA06
ATC
trimipramine; systemic
9.8
42.3
51
57
N05CD02
ATC
nitrazepam; oral
14.5
42.1
39
29
N06AX05
ATC
trazodone; oral
8.7
39.0
52
66
P72
ICPC
Schizophrenia
9.1
38.3
49
59
F05.9
ICD-10 Finland
Delirium, unspecified
16.0
37.7
33
22
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
13.3
37.0
36
29
Z72.1
ICD-10 Finland
Alcohol use
11.7
35.9
38
35
P16
ICPC
Acute alcohol abuse
9.7
35.6
43
48
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
72.2
35.5
40
6
F31
ICD-10 Finland
Bipolar affective disorder
12.9
35.4
35
29
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
50.8
35.3
42
9
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
14.8
35.1
32
23
F61
ICD-10 Finland
Mixed and other personality disorders
55.6
35.0
41
8
T74.1
ICD-10 Finland
Physical abuse
9.2
34.9
44
52
WX892
NOMESCO Finland
Monitored bed care
5.2
34.2
78
172
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
5.3
33.4
74
159
TKC20
NOMESCO Finland
Catheterisation of bladder
5.5
32.2
67
136
ZY000
NOMESCO Finland
Hospital inpatient
11.0
31.9
35
34
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.7
31.7
120
389
F31.8
ICD-10 Finland
Other bipolar affective disorders
8.3
31.5
43
56
N06AB10
ATC
escitalopram; oral
3.1
31.2
187
804
N06AA09
ATC
amitriptyline; systemic
4.3
30.9
91
246
G40.9
ICD-10 Finland
Epilepsy, unspecified
7.3
30.7
47
70
R03BB04
ATC
tiotropium bromide; inhalant
4.6
30.1
79
195
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
37.2
30.1
38
11
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
37.2
30.1
38
11
IGY02
NOMESCO Finland
Psychiatric monitoring contact
6.0
28.8
54
99
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
33.2
28.6
37
12
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
9.3
28.4
35
40
S01.0
ICD-10 Finland
Open wound of scalp
4.6
28.3
74
182
S06.0
ICD-10 Finland
Concussion
3.8
28.1
100
309
AA1AD
NOMESCO Finland
CT of head and brain
2.9
27.9
186
840
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.0
27.8
166
705
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.6
27.5
109
362
ZY010
NOMESCO Finland
Hospital outpatient
4.7
27.1
69
166
Z91.5
ICD-10 Finland
Personal history of self-harm
148.0
26.9
28
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.8
26.8
195
920
SPAT1240
SPAT
Therapeutic discussion
3.6
26.4
103
338
F99
ICD-10 Finland
Mental disorder, not otherwise specified
7.7
26.2
38
53
EBA00
NOMESCO Finland
Extraction of tooth
2.7
25.9
249
1348
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
30.3
25.7
34
12
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
6.9
25.6
41
64
T42.4
ICD-10 Finland
Poisoning: Benzodiazepines
53.0
25.5
30
6
K59.09
ICD-10 Finland
Constipation, unspecified
4.7
25.5
64
152
N05CF02
ATC
zolpidem; oral
3.0
25.5
144
590
F39
ICD-10 Finland
Unspecified mood [affective] disorder
8.4
25.4
34
43
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.6
25.4
66
161
P76
ICPC
Depressive disorder
4.0
25.4
82
236
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
5.9
25.3
48
89
N06AX12
ATC
bupropion; oral
3.9
25.2
85
252
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
22.7
25.1
36
17
N05CD08
ATC
midazolam; nasal, systemic
9.6
25.0
30
33
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.6
24.9
94
301
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
21.5
24.7
36
18
2961D
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]
51.1
24.5
29
6
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
51.1
24.5
29
6
9690A
ICD-9 Finland
Poisoning by psychotropic agents, Antidepressants
51.1
24.5
29
6
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.7
24.4
87
268
N05AL01
ATC
sulpiride; systemic
10.2
24.3
28
29
N06AA04
ATC
clomipramine; systemic
8.9
24.3
31
37
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
3.8
24.2
84
254
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
6.7
23.9
39
62
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
8.6
23.7
31
38
IHZ04, ,
SPAT
7.7
23.6
34
47
SPAT1307
SPAT
Psychosocial counselling and guidance
4.4
23.0
63
160
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
125.8
22.8
24
*
F34.1
ICD-10 Finland
Dysthymia
4.7
22.6
55
127
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
28.9
22.5
30
11
P06
ICPC
Sleep disturbance
3.0
22.4
118
461
A28
ICPC
Limited function/disability NOS
3.4
22.2
94
323
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.8
22.0
73
213
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
5.2
22.0
48
101
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
40.7
21.9
27
7
A02BC01
ATC
omeprazole; systemic
2.6
21.9
170
814
C03CA01
ATC
furosemide; systemic
2.8
21.9
139
601
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.5
21.8
243
1379
N03AX16
ATC
[U] pregabalin
2.7
21.8
163
766
Z2446
NOMESCO Finland
Social worker
4.1
21.8
65
176
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
18.5
21.6
33
19
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
20.0
21.6
32
17
Z72.2
ICD-10 Finland
Drug use
52.5
21.3
25
5
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
25.6
21.1
29
12
R41.0
ICD-10 Finland
Disorientation, unspecified
7.7
21.0
30
41
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.5
20.9
54
131
K59.0
ICD-10 Finland
Constipation
4.8
20.8
50
114
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
31.6
20.8
27
9
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
26.8
20.7
28
11
X59
ICD-10 Finland
Exposure to unspecified factor
2.7
20.6
142
639
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
5.2
20.5
44
91
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.3
20.4
87
299
P74
ICPC
Anxiety disorder/anxiety state
4.1
20.3
60
161
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
19.9
20.2
30
16
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.3
20.2
85
290
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
4.6
20.0
50
118
X78
ICD-10 Finland
Intentional self-harm by sharp object
22.7
19.7
28
13
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
5.6
19.7
39
75
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
7.7
19.7
28
38
K92.0
ICD-10 Finland
Haematemesis
7.3
19.3
29
42
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
23.7
19.3
27
12
R02
ICPC
Shortness of breath/dyspnoea
3.0
19.1
98
375
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
5.3
19.1
40
81
SPAT1243
SPAT
Psychiatric/psychological examination
6.1
19.1
34
59
N05AC01
ATC
periciazine; systemic
57.4
19.1
22
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
19.1
177
913
K08.3
ICD-10 Finland
Retained dental root
3.7
19.1
66
198
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
5.6
19.0
37
70
OAB43, ,
SPAT
0.3
19.0
59
1569
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.6
18.9
68
209
F19.30
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated
104.0
18.7
20
*
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
17.0
18.5
29
18
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
31.4
18.5
24
8
S00.0
ICD-10 Finland
Superficial injury of scalp
6.9
18.5
29
44
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
20.3
18.4
27
14
P19
ICPC
Drug abuse
20.3
18.4
27
14
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
4.5
18.3
46
109
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
16.1
18.2
29
19
R07.4
ICD-10 Finland
Chest pain, unspecified
2.4
18.2
176
922
AA400
NOMESCO Finland
Electroconvulsive therapy
17.4
18.1
28
17
SPAT1234
SPAT
Support of social functional capacity
5.1
17.8
39
82
IGY99, ,
SPAT
6.8
17.6
28
43
F60.7
ICD-10 Finland
Dependent personality disorder
30.0
17.6
23
8
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
25.1
17.5
24
10
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.3
17.4
190
1044
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.8
17.4
100
406
P03
ICPC
Feeling depressed
2.9
17.3
91
352
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.9
17.3
53
146
ZXD35
NOMESCO Finland
Usual procedure
5.5
17.0
34
66
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.1
16.8
49
130
R95
ICPC
Chron obstructive pulmonary disease
7.6
16.7
24
33
N03AF02
ATC
oxcarbazepine; oral
4.8
16.6
39
87
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
41.6
16.4
20
5
2961C
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]
41.6
16.4
20
5
F51.0
ICD-10 Finland
Nonorganic insomnia
2.4
16.4
138
674
Z71.8
ICD-10 Finland
Other specified counselling
2.2
16.2
217
1290
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
25.5
16.1
22
9
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
5.6
16.1
31
58
Z3231
NOMESCO Finland
Registered nurse
2.3
16.0
167
896
F25.2
ICD-10 Finland
Schizoaffective disorder, mixed type
62.1
15.9
18
*
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
17.9
15.8
24
14
R06.0
ICD-10 Finland
Dyspnoea
2.3
15.5
161
859
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.1
15.5
45
119
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
4.3
15.5
41
101
N02AX02
ATC
tramadol; systemic, rectal
2.1
15.5
251
1600
SPAT1254
SPAT
Administration of medicine
2.8
15.4
87
349
P18
ICPC
Medication abuse
13.6
15.3
26
20
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
11.3
15.2
28
26
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
13.0
15.0
26
21
P01
ICPC
Feeling anxious/nervous/tense
2.6
15.0
102
449
R51.80
ICD-10 Finland
Headache
2.4
15.0
121
578
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.6
15.0
51
151
A02BC03
ATC
lansoprazole; oral
2.2
14.9
168
926
R11
ICD-10 Finland
Nausea and vomiting
3.1
14.9
69
248
F60.8
ICD-10 Finland
Other specific personality disorders
25.9
14.8
20
8
A02BA02
ATC
ranitidine; systemic
2.5
14.7
108
493
T36N0, ,
ICD-10 Finland
+∞
14.7
14
*
ZXD05
NOMESCO Finland
Urgent procedure
2.2
14.6
184
1059
R33
ICD-10 Finland
Retention of urine
3.8
14.6
47
134
R53
ICD-10 Finland
Malaise and fatigue
2.2
14.6
158
856
A46
ICD-10 Finland
Erysipelas
2.7
14.5
88
366
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
17.6
14.4
22
13
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.4
14.4
56
181
S10
ICPC
Boil/carbuncle
3.4
14.3
54
171
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
5.9
14.3
26
46
IGY99
NOMESCO Finland
Other psychiatric treatment contact
5.3
14.3
29
57
EBA15
NOMESCO Finland
Extraction of multiple teeth
4.7
14.2
34
77
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
12.5
14.2
25
21
K92.1
ICD-10 Finland
Melaena
4.2
14.2
39
99
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
4.5
14.1
35
82
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
13.2
14.0
24
19
N03AX12
ATC
[U] gabapentin; oral
2.4
14.0
111
525
A02BA04
ATC
nizatidine; systemic
3.5
13.9
50
153
F21
ICD-10 Finland
Schizotypal disorder
20.8
13.9
20
10
Z29
ICPC
Social problem NOS
6.5
13.9
23
37
EBA30
NOMESCO Finland
Extraction of root of tooth
3.6
13.8
47
139
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
6.1
13.6
24
41
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
6.1
13.6
24
41
K85
ICD-10 Finland
Acute pancreatitis
10.5
13.6
26
26
F25.1
ICD-10 Finland
Schizoaffective disorder, depressive type
35.1
13.6
17
5
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
18.9
13.5
20
11
Z72.8
ICD-10 Finland
Other problems related to lifestyle
18.9
13.5
20
11
F60.2
ICD-10 Finland
Dissocial personality disorder
26.6
13.4
18
7
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
26.6
13.4
18
7
R60.9
ICD-10 Finland
Oedema, unspecified
3.7
13.4
44
127
D12
ICPC
Constipation
4.6
13.3
32
73
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.1
13.2
189
1133
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.7
13.1
43
124
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.5
13.1
90
397
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
17.3
13.1
20
12
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.7
13.0
77
315
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
4.7
13.0
31
70
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
23.3
13.0
18
8
M01AE03
ATC
ketoprofen; systemic, rectal
2.0
13.0
203
1255
F22.0
ICD-10 Finland
Delusional disorder
10.1
12.9
25
26
WX730
NOMESCO Finland
Conventional respirator
14.6
12.9
21
15
N06AX21
ATC
duloxetine; oral
2.5
12.8
94
427
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.3
12.8
125
644
C07AB07
ATC
bisoprolol; oral
2.0
12.7
234
1529
K59.1
ICD-10 Finland
Functional diarrhoea
3.5
12.6
46
142
W19
ICD-10 Finland
Unspecified fall
2.9
12.6
64
241
E970A
ICD-9 Finland
Injury due to legal intervention by firearms
33.0
12.6
16
5
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
4.3
12.5
33
81
F25
ICD-10 Finland
Schizoaffective disorders
133.2
12.5
13
*
-1, ,
NOMESCO Finland
2.0
12.5
205
1285
F41.1
ICD-10 Finland
Generalized anxiety disorder
3.1
12.5
54
186
30041
ICD-8 Finland
Neuroses, Depressiva
12.1
12.4
22
19
Z00.0
ICD-10 Finland
General medical examination
2.3
12.3
117
595
L17
ICPC
Foot/toe symptom/complaint
2.0
12.3
175
1042
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
3.5
12.2
44
135
J45.9
ICD-10 Finland
Asthma, unspecified
2.3
12.2
116
590
IHZ05, ,
SPAT
3.6
12.2
42
125
R60.0
ICD-10 Finland
Localized oedema
2.7
12.2
74
307
P80
ICPC
Personality disorder
27.5
12.1
16
6
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
12.0
62
236
D64.9
ICD-10 Finland
Anaemia, unspecified
3.0
12.0
55
196
IGV01
NOMESCO Finland
Psychiatric network contact
10.0
11.9
23
24
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.3
11.8
24
47
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.0
11.8
166
980
WX110
NOMESCO Finland
Infiltration anesthesia
2.2
11.8
396
3160
F40.1
ICD-10 Finland
Social phobias
4.6
11.8
28
63
J01FF01
ATC
clindamycin; systemic
2.1
11.8
159
926
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.9
11.7
271
1896
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
30.8
11.7
15
5
F25.11
ICD-10 Finland
Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms
30.8
11.7
15
5
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.2
11.7
121
636
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
19.5
11.7
17
9
OAA67, ,
SPAT
0.2
11.6
20
787
SPAT1265
SPAT
Breathalyser
9.6
11.6
23
25
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
14.1
11.5
19
14
T43.3
ICD-10 Finland
Poisoning: Phenothiazine antipsychotics and neuroleptics
122.7
11.5
12
*
T43.0
ICD-10 Finland
Poisoning: Tricyclic and tetracyclic antidepressants
122.7
11.5
12
*
J01DA01
ATC
[U] cefalexin
2.0
11.4
333
2511
F43.1
ICD-10 Finland
Post-traumatic stress disorder
4.2
11.4
31
78
ZXE20
NOMESCO Finland
More than three and less than five hours
2.5
11.3
80
356
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.5
11.3
40
121
F10.03
ICD-10 Finland
Alcohol-related acute intoxication with delirium
35.9
11.3
14
*
N05BB01
ATC
hydroxyzine; systemic
3.2
11.2
46
153
N02BF02
ATC
pregabalin; oral
3.0
11.2
52
186
ICB03, ,
SPAT
25.7
11.2
15
6
Z02.7
ICD-10 Finland
Issue of medical certificate
2.9
11.1
55
204
M79.6
ICD-10 Finland
Pain in limb
1.9
11.1
253
1751
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
5.9
11.1
20
35
SPAT1301
SPAT
No procedures
2.0
11.1
156
919
Z3226
NOMESCO Finland
Physiotherapist
2.2
11.1
105
532
L28
ICPC
Limited function/disability (L)
2.3
11.1
92
441
V03AB30, ,
ATC
14.3
11.0
18
13
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.5
11.0
73
315
R52.9
ICD-10 Finland
Pain, unspecified
2.5
11.0
73
316
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
10.9
118
630
A01
ICPC
Pain general/multiple sites
2.6
10.8
70
299
9691A
ICD-9 Finland
Poisoning by psychotropic agents, Phenothiazine-based tranquillisers
28.7
10.8
14
5
30180
ICD-8 Finland
Personality disorders, Immatura
22.0
10.7
15
7
R07.3
ICD-10 Finland
Other chest pain
2.5
10.7
71
307
A04
ICPC
Weakness/tiredness general
2.3
10.6
90
435
Z72.0
ICD-10 Finland
Tobacco use
4.2
10.6
28
69
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
12.4
10.4
18
15
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
12.4
10.4
18
15
N05AE04
ATC
ziprasidone; systemic
12.4
10.4
18
15
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
16.5
10.4
16
10
Z63.0
ICD-10 Finland
Problems in relationship with spouse or partner
16.5
10.4
16
10
E9509
ICD-8 Finland
Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances
16.5
10.4
16
10
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
33.3
10.4
13
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
10.4
238
1641
F25.21
ICD-10 Finland
Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms
19.3
10.3
15
8
Z2221
NOMESCO Finland
Medical doctor
2.0
10.3
157
947
K07
ICPC
Swollen ankles/oedema
3.9
10.3
31
84
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
7.7
10.3
23
31
A07DA03
ATC
loperamide; oral
4.4
10.2
26
62
F41.09
ICD-10 Finland
UNS Panic Syndrome
3.9
10.2
30
80
L03
ICPC
Low back symptom/complaint
1.9
10.2
169
1049
UJF32
NOMESCO Finland
Coloscopy
2.0
10.1
129
730
N05BA05
ATC
potassium clorazepate; oral
11.6
10.1
18
16
N06AX18
ATC
reboxetine; oral
10.3
10.1
19
19
F50.9
ICD-10 Finland
Eating disorder, unspecified
15.0
10.1
16
11
IEV99, ,
SPAT
40.9
10.0
12
*
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.6
9.9
59
241
S42.2
ICD-10 Finland
Fracture of upper end of humerus
3.7
9.9
32
91
F10.3
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state
17.1
9.9
15
9
F20.0
ICD-10 Finland
Paranoid schizophrenia
12.5
9.9
17
14
P98
ICPC
Psychosis NOS/other
12.5
9.9
17
14
WX290
NOMESCO Finland
Other blockage of nerve
1.8
9.9
287
2117
N07BA03
ATC
varenicline; oral
3.0
9.9
44
154
R5110, ,
SPAT
2.8
9.9
51
194
F60.0
ICD-10 Finland
Paranoid personality disorder
26.6
9.9
13
5
D07AA02
ATC
hydrocortisone; topical
2.2
9.8
92
462
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.0
9.8
28
73
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
13.7
9.7
16
12
N06AA22, ,
ATC
13.7
9.7
16
12
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.3
9.7
86
422
Z2445
NOMESCO Finland
Psychologist
3.4
9.6
36
113
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
5.2
9.6
20
40
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
8.6
9.6
20
24
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
8.6
9.6
20
24
S18
ICPC
Laceration/cut
1.8
9.6
242
1705
S61.8
ICD-10 Finland
Open wound of other parts of wrist and hand
4.3
9.5
25
61
K10.3
ICD-10 Finland
Alveolitis of jaws
3.0
9.5
44
157
A11
ICPC
Chest pain NOS
2.8
9.5
51
198
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.0
9.5
114
631
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
9.4
225
1556
F13.00
ICD-10 Finland
Intoxication caused by sedatives and hypnotics uncomplicated
101.9
9.4
10
*
3016A
ICD-9 Finland
Personality disorders, Dependent personality disorder
101.9
9.4
10
*
M54.5
ICD-10 Finland
Low back pain
1.8
9.4
208
1405
V03AA02, ,
ATC
+∞
9.4
9
*
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
4.8
9.4
21
45
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.6
9.4
58
242
G81.9
ICD-10 Finland
Hemiplegia, unspecified
11.0
9.3
17
16
F32.1
ICD-10 Finland
Moderate depressive episode
2.6
9.3
55
224
N30.0
ICD-10 Finland
Acute cystitis
2.1
9.3
94
486
SPA47
NOMESCO Finland
Precision impression for denture
4.3
9.3
24
58
SFA10
NOMESCO Finland
One-surface restoration
1.8
9.2
310
2367
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.5
9.2
59
250
F20.3
ICD-10 Finland
Undifferentiated schizophrenia
14.0
9.2
15
11
G72.8
ICD-10 Finland
Other specified myopathies
8.0
9.2
20
26
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.9
9.2
170
1086
Y04.0
ICD-10 Finland
Assault by bodily force by spouse or partner
16.0
9.1
14
9
SPAT1229
SPAT
Assessment of need for aid
3.2
9.0
36
118
X84
ICD-10 Finland
Intentional self-harm by unspecified means
19.0
9.0
13
7
F13.2
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome
19.0
9.0
13
7
F13.3
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state
19.0
9.0
13
7
P73
ICPC
Affective psychosis
19.0
9.0
13
7
X58
ICD-10 Finland
Exposure to other specified factors
2.1
9.0
94
493
N30.9
ICD-10 Finland
Cystitis, unspecified
2.9
9.0
43
157
F13.21
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment
24.5
8.9
12
5
L12
ICPC
Hand/finger symptom/complaint
2.0
8.9
107
590
30188
ICD-8 Finland
Personality disorders, Alia definita
12.8
8.9
15
12
T51.0
ICD-10 Finland
Toxic effect: Ethanol
12.8
8.9
15
12
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.0
8.9
39
135
OAA80, ,
SPAT
0.2
8.9
8
404
ZXE00
NOMESCO Finland
One hour or less
1.8
8.9
201
1362
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.2
8.9
81
402
S22.3
ICD-10 Finland
Fracture of rib
2.7
8.9
51
205
F20
ICD-10 Finland
Schizophrenia
8.8
8.9
18
21
SPAT1235
SPAT
Mental health, emotional support
11.0
8.8
16
15
K05.31
ICD-10 Finland
Periodontitis pronounced
2.3
8.8
71
334
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.6
8.8
29
84
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
4.4
8.7
22
52
N02AA05
ATC
oxycodone; systemic
2.2
8.7
84
426
N06AX22
ATC
agomelatine; oral
4.1
8.7
24
61
A02BC02
ATC
pantoprazole; systemic
1.8
8.7
344
2737
S00.8
ICD-10 Finland
Superficial injury of other parts of head
4.7
8.7
20
44
E66.8
ICD-10 Finland
Other obesity
2.8
8.6
45
172
3092E
ICD-9 Finland
Adjustment reaction, With predominant disturbance of other emotions[USEINA EMOTIONAALISINA OIREINA ILM.SOPEUTUMISHÄIRIÖ]
16.6
8.6
13
8
KMAK, ,
NOMESCO Finland
1.8
8.5
285
2153
Z71
ICD-10 Finland
Persons encountering health services for other counselling and medical advice, not elsewhere classified
3.5
8.5
29
86
WX872
NOMESCO Finland
Intensive care
3.2
8.4
34
112
F10.04
ICD-10 Finland
Alcohol-related acute intoxication with hallucinations
91.5
8.4
9
*
R40.2
ICD-10 Finland
Coma, unspecified
13.1
8.4
14
11
F69
ICD-10 Finland
Unspecified disorder of adult personality and behaviour
+∞
8.4
8
*
F19.22
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication
+∞
8.4
8
*
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
11.0
8.3
15
14
XF600
NOMESCO Finland
Bloodpressure measurement
3.1
8.3
36
124
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.8
8.3
42
158
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
6.7
8.3
20
31
K02.1
ICD-10 Finland
Caries of dentine
1.8
8.2
328
2592
IFA99, ,
SPAT
14.8
8.2
13
9
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.3
8.2
31
98
N03AX11
ATC
topiramate; oral
3.6
8.2
27
78
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.5
8.2
28
83
S93.4
ICD-10 Finland
Sprain and strain of ankle
2.2
8.2
78
394
A08
ICPC
Swelling
3.1
8.1
35
120
Z50.7
ICD-10 Finland
Occupational therapy and vocational rehabilitation, not elsewhere classified
12.0
8.1
14
12
F60.1
ICD-10 Finland
Schizoid personality disorder
33.9
8.1
10
*
97010
ICD-8 Finland
Adverse effect of psychotherapeutics, Tranquillisers
33.9
8.1
10
*
P77
ICPC
Suicide/suicide attempt
33.9
8.1
10
*
R42
ICD-10 Finland
Dizziness and giddiness
1.9
8.1
111
640
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
22.4
8.0
11
5
F19.2
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome
22.4
8.0
11
5
S82.6
ICD-10 Finland
Fracture of lateral malleolus
2.7
8.0
44
173
-, ,
ICD-10 Finland
6.8
8.0
19
29
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
7.9
55
242
Y07
ICD-10 Finland
Other maltreatment
8.0
7.9
17
22
Y94.0
ICD-10 Finland
Accident at home
6.3
7.9
20
33
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
7.9
175
1170
F10.22
ICD-10 Finland
Alcohol dependence is currently on clinically controlled discontinuation medication
13.3
7.9
13
10
S82.8
ICD-10 Finland
Fractures of other parts of lower leg
3.5
7.9
27
80
I84
ICD-10 Finland
Hemorrhoids
4.2
7.9
21
52
SPAT1227
SPAT
Substance abuse rehabilitation
11.0
7.8
14
13
IFA01, ,
SPAT
11.0
7.8
14
13
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
7.1
7.8
18
26
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
3.8
7.8
24
66
G44.2
ICD-10 Finland
Tension-type headache
2.1
7.8
86
458
F41.8
ICD-10 Finland
Other specified anxiety disorders
3.3
7.8
29
91
OAA65, ,
SPAT
0.4
7.8
37
866
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
6.5
7.8
19
30
OAB48, ,
SPAT
0.3
7.8
26
718
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
3.5
7.8
27
81
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
6.1
7.8
20
34
3004A
ICD-9 Finland
Neurotic disorders, Neurotic depression
15.3
7.7
12
8
F11.30
ICD-10 Finland
Withdrawal symptoms caused by opiates uncomplicated
45.7
7.7
9
*
F43.2
ICD-10 Finland
Adjustment disorders
4.6
7.7
18
40
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
7.7
131
809
OAB95, ,
SPAT
0.2
7.7
7
352
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
3.3
7.7
29
92
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
7.7
240
1763
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.7
7.6
301
2349
S02
ICPC
Pruritus
3.3
7.6
28
87
9800A
ICD-9 Finland
Toxic effect of alcohol, Ethyl alcohol
18.7
7.6
11
6
A29
ICPC
General symptom/complaint other
2.1
7.6
75
383
F50.2
ICD-10 Finland
Bulimia nervosa
12.1
7.6
13
11
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
12.1
7.6
13
11
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
4.2
7.6
20
49
F10.52
ICD-10 Finland
Psychotic alcohol hallucination
25.4
7.6
10
*
H03AA01
ATC
levothyroxine sodium; systemic
1.8
7.6
125
764
JN3AD
NOMESCO Finland
Abdominal CT examination
2.1
7.6
77
398
R05
ICPC
Cough
1.8
7.6
139
878
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
3.8
7.5
23
63
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
2.2
7.5
67
329
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
4.0
7.5
21
54
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.6
7.5
46
191
Z46.3
ICD-10 Finland
Fitting and adjustment of dental prosthetic device
6.6
7.5
18
28
R06AE07
ATC
cetirizine; oral
1.7
7.5
230
1678
T42.7
ICD-10 Finland
Poisoning: Antiepileptic and sedative-hypnotic drugs, unspecified
81.3
7.4
8
*
3092D
ICD-9 Finland
Adjustment reaction, With predominant disturbance of other emotions[AHDISTUNEISUUTENA ILMENEVÄ SOPEUTUMISHÄIRIÖ]
81.3
7.4
8
*
ZYD04
NOMESCO Finland
Emergency outreach service, another specialty
81.3
7.4
8
*
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
13.6
7.4
12
9
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.7
7.4
23
64
SPA02
NOMESCO Finland
Preparation for dental prosthetics
3.5
7.3
25
74
WX704
NOMESCO Finland
Intubation
2.5
7.3
49
212
IER01
NOMESCO Finland
Psychoeducation, group
9.6
7.3
14
15
R4110
NOMESCO Finland
Physiotherapy
1.8
7.3
143
919
S76
ICPC
Skin infection other
2.8
7.3
38
145
F15.3
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state
+∞
7.3
7
*
SPAT1276
SPAT
Outlining of treatment with patient or their family members
6.4
7.3
18
29
S09.9
ICD-10 Finland
Unspecified injury of head
6.4
7.3
18
29
W17
ICD-10 Finland
Other fall from one level to another
3.2
7.3
29
95
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
16.0
7.3
11
7
U04
ICPC
Incontinence urine
3.1
7.3
31
106
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.5
7.2
45
188
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.8
7.2
134
847
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.6
7.2
17
38
R51
ICD-10 Finland
Headache
2.6
7.2
41
164
R63.4
ICD-10 Finland
Abnormal weight loss
3.4
7.2
26
80
K04.08
ICD-10 Finland
Other specified pulpit
2.3
7.2
58
273
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
2.4
7.2
51
227
T00.9
ICD-10 Finland
Multiple superficial injuries, unspecified
30.5
7.2
9
*
N05AA03
ATC
promazine; systemic
30.5
7.2
9
*
F19.39
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances UNS
30.5
7.2
9
*
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
3.1
7.2
29
96
SPAT1247
SPAT
Outpatient detoxication and monitoring
20.4
7.2
10
5
30088
ICD-8 Finland
Neuroses, Other
20.4
7.2
10
5
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
8.1
7.1
15
19
A10BA02
ATC
metformin; oral
1.8
7.1
131
826
N03AX18
ATC
lacosamide; systemic
10.2
7.1
13
13
S61.9
ICD-10 Finland
Open wound of wrist and hand, part unspecified
3.4
7.1
25
76
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.3
7.0
56
262
K04.1
ICD-10 Finland
Necrosis of pulp
2.1
7.0
72
373
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.0
7.0
18
31
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.2
7.0
61
297
L02.8
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of other sites
4.1
7.0
19
48
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.0
6.9
79
426
F11.20
ICD-10 Finland
Addiction-induced dependence caused by opiates currently independent
14.0
6.9
11
8
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.0
6.9
76
405
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
8.4
6.9
14
17
S51.0
ICD-10 Finland
Open wound of elbow
8.4
6.9
14
17
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
6.8
135
868
IHZ07, ,
SPAT
9.5
6.8
13
14
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.7
6.8
21
58
N06AX26
ATC
vortioxetine; oral
2.3
6.8
52
239
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
40.6
6.8
8
*
F92.0
ICD-10 Finland
Depressive conduct disorder
40.6
6.8
8
*
3041A
ICD-9 Finland
Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence
40.6
6.8
8
*
T43.2
ICD-10 Finland
Poisoning: Other and unspecified antidepressants
40.6
6.8
8
*
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
4.0
6.8
19
49
Z03
ICPC
Housing/neighbourhood problem
17.0
6.8
10
6
183
Kela drug reimbursment
Lamotrigin and topiramate
7.3
6.7
15
21
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
6.7
67
344
F31.21
ICD-10 Finland
Bipolar disorder, manic episode with mood incongruent psychotic symptoms
22.9
6.7
9
*
Y04.2
ICD-10 Finland
Assault by bodily force by friend
22.9
6.7
9
*
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
4.1
6.7
18
45
F41.3
ICD-10 Finland
Other mixed anxiety disorders
5.6
6.7
18
33
P01AB01
ATC
metronidazole; oral, rectal
1.6
6.7
216
1584
Z73.9
ICD-10 Finland
Problem related to life-management difficulty, unspecified
8.0
6.7
14
18
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
12.5
6.6
11
9
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
6.6
110
673
F33
ICD-10 Finland
Recurrent depressive disorder
3.3
6.5
24
75
E66.9
ICD-10 Finland
Obesity, unspecified
3.0
6.5
29
102
M54.4
ICD-10 Finland
Lumbago with sciatica
1.8
6.5
108
660
30000
ICD-8 Finland
Neuroses, Anxiety neurosis
7.5
6.4
14
19
F11.21
ICD-10 Finland
Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment
70.7
6.4
7
*
Y87.0
ICD-10 Finland
Sequelae of intentional self-harm
70.7
6.4
7
*
WYA10
NOMESCO Finland
Emergency care or similar visit
2.3
6.4
47
212
F25.0
ICD-10 Finland
Schizoaffective disorder, manic type
14.5
6.4
10
7
F20.01
ICD-10 Finland
Paranoid schizophrenia periodically with gradual deterioration
14.5
6.4
10
7
U01
ICPC
Dysuria/painful urination
2.4
6.4
43
187
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
8.3
6.4
13
16
SPAT1260
SPAT
Consultation of another employee
1.9
6.4
82
461
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
6.4
94
553
S20.2
ICD-10 Finland
Contusion of thorax
2.6
6.3
37
150
NHJ10
NOMESCO Finland
Internal fixation of fracture of ankle using wire, rod, cerclage or pin
2.9
6.3
30
109
WX890
NOMESCO Finland
Intesive care monitoring
11.2
6.3
11
10
IEV99
NOMESCO Finland
Other psychiatric network intervention
11.2
6.3
11
10
G04BD04
ATC
oxybutynin; oral, transdermal
2.8
6.3
31
115
K29.2
ICD-10 Finland
Alcoholic gastritis
18.3
6.3
9
5
ZX122
NOMESCO Finland
Intra-arterial
18.3
6.3
9
5
29630
ICD-8 Finland
Affective psychoses, Manic-depressive psychosis, circular type
+∞
6.3
6
*
N05CM02
ATC
clomethiazole; systemic
+∞
6.3
6
*
F10.02
ICD-10 Finland
Alcohol-related acute intoxication with other acute clinical complications
27.0
6.2
8
*
F10.4
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium
27.0
6.2
8
*
S62.6
ICD-10 Finland
Fracture of other finger
2.8
6.2
30
110
X15
ICPC
Vaginal symptom/complaint other
2.8
6.2
30
110
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
3.4
6.2
22
67
P27
ICPC
Fear of mental disorder
5.5
6.2
17
32
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.1
6.2
57
284
J01MA02
ATC
ciprofloxacin; systemic
1.6
6.1
179
1272
N03AX14
ATC
levetiracetam; systemic
3.7
6.1
19
53
D11
ICPC
Diarrhoea
2.0
6.1
72
393
LCH00
NOMESCO Finland
Vacuum aspiration of products of conception from uterus
3.6
6.1
20
58
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
10.2
6.1
11
11
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
10.2
6.1
11
11
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.4
6.0
41
179
U13
ICPC
Bladder symptom/complaint other
4.0
6.0
17
44
ZXA05
NOMESCO Finland
Left side
1.8
6.0
108
673

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Psychiatry
26 [38004469]
3.7e+00
3.7e+00
3.8e+00
1.0e+50
4.8e+00
4.0e+00
3.5e+00
cases:42.17%
controls:1.85%
cases:41.97%
controls:1.75%
cases:22.29%
controls:0.66%
cases:19.68%
controls:0.00%
cases:43.37%
controls:0.62%
cases:51.31%
controls:1.90%
cases:61.84%
controls:4.68%
210
92
288
4880
209
87
289
4885
111
33
387
4939
98
0
400
4972
216
31
282
4941
254
94
241
4863
303
230
187
4684
temazepam; oral
N05CD07 [21604642]
2.8e+00
3.1e+00
3.8e+00
—
3.7e+00
3.4e+00
3.1e+00
cases:23.09%
controls:1.79%
cases:15.06%
controls:0.76%
cases:6.22%
controls:0.14%
—
—
cases:3.82%
controls:0.10%
cases:13.54%
controls:0.52%
cases:23.06%
controls:1.30%
115
89
383
4883
75
38
423
4934
31
7
467
4965
—
19
5
479
4967
67
26
428
4931
113
64
377
4850
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
2.6e+00
2.9e+00
3.7e+00
—
3.2e+00
3.3e+00
3.0e+00
cases:23.90%
controls:2.23%
cases:16.87%
controls:1.13%
cases:6.63%
controls:0.18%
—
—
cases:6.22%
controls:0.28%
cases:17.78%
controls:0.81%
cases:21.63%
controls:1.30%
119
111
379
4861
84
56
414
4916
33
9
465
4963
—
31
14
467
4958
88
40
407
4917
106
64
384
4850
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
2.4e+00
2.6e+00
3.0e+00
—
3.3e+00
3.3e+00
3.4e+00
cases:4.62%
controls:0.42%
cases:5.62%
controls:0.42%
cases:3.21%
controls:0.16%
—
—
cases:3.82%
controls:0.14%
cases:9.90%
controls:0.42%
cases:20.00%
controls:0.79%
23
21
475
4951
28
21
470
4951
16
8
482
4964
—
19
7
479
4965
49
21
446
4936
98
39
392
4875
olanzapine; oral, parenteral
N05AH03 [21604543]
2.7e+00
3.2e+00
—
—
3.4e+00
4.1e+00
3.6e+00
cases:3.61%
controls:0.26%
cases:5.02%
controls:0.22%
—
—
—
—
cases:2.81%
controls:0.10%
cases:9.90%
controls:0.18%
cases:18.16%
controls:0.63%
18
13
480
4959
25
11
473
4961
—
—
14
5
484
4967
49
9
446
4948
89
31
401
4883
oxazepam; oral
N05BA04 [21604569]
2.6e+00
2.7e+00
3.0e+00
—
3.0e+00
2.9e+00
2.5e+00
cases:20.88%
controls:1.99%
cases:15.06%
controls:1.17%
cases:6.43%
controls:0.34%
—
—
cases:5.42%
controls:0.28%
cases:16.97%
controls:1.07%
cases:20.82%
controls:2.22%
104
99
394
4873
75
58
423
4914
32
17
466
4955
—
27
14
471
4958
84
53
411
4904
102
109
388
4805
chlorprothixene; oral, parenteral
N05AF03 [21604533]
4.5e+00
4.0e+00
—
—
—
4.1e+00
3.9e+00
cases:8.03%
controls:0.10%
cases:5.42%
controls:0.10%
—
—
—
—
—
—
cases:5.66%
controls:0.10%
cases:9.39%
controls:0.20%
40
5
458
4967
27
5
471
4967
—
—
—
28
5
467
4952
46
10
444
4904
zopiclone; oral
N05CF01 [21604654]
2.7e+00
2.7e+00
3.3e+00
—
2.9e+00
2.4e+00
2.2e+00
cases:28.31%
controls:2.63%
cases:19.28%
controls:1.63%
cases:6.83%
controls:0.28%
—
—
cases:5.02%
controls:0.30%
cases:14.75%
controls:1.49%
cases:23.47%
controls:3.32%
141
131
357
4841
96
81
402
4891
34
14
464
4958
—
25
15
473
4957
73
74
422
4883
115
163
375
4751
levomepromazine; oral, parenteral
N05AA02 [21604493]
3.9e+00
3.9e+00
—
—
—
4.2e+00
4.0e+00
cases:12.65%
controls:0.28%
cases:8.43%
controls:0.18%
—
—
—
—
—
—
cases:10.71%
controls:0.18%
cases:16.94%
controls:0.39%
63
14
435
4958
42
9
456
4963
—
—
—
53
9
442
4948
83
19
407
4895
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
3.3e+00
4.4e+00
—
1.0e+50
—
4.1e+00
3.6e+00
cases:8.63%
controls:0.34%
cases:7.83%
controls:0.10%
—
—
cases:4.42%
controls:0.00%
—
—
cases:10.71%
controls:0.20%
cases:17.35%
controls:0.57%
43
17
455
4955
39
5
459
4967
—
22
0
476
4972
—
53
10
442
4947
85
28
405
4886
fluoxetine; oral
N06AB03 [21604711]
2.5e+00
2.7e+00
2.8e+00
—
2.9e+00
2.5e+00
2.0e+00
cases:21.49%
controls:2.29%
cases:13.45%
controls:1.05%
cases:4.62%
controls:0.28%
—
—
cases:4.02%
controls:0.22%
cases:13.13%
controls:1.23%
cases:14.29%
controls:2.28%
107
114
391
4858
67
52
431
4920
23
14
475
4958
—
20
11
478
4961
65
61
430
4896
70
112
420
4802
citalopram; oral, parenteral
N06AB04 [21604712]
2.5e+00
2.5e+00
2.7e+00
—
2.9e+00
2.7e+00
2.1e+00
cases:20.88%
controls:2.19%
cases:14.26%
controls:1.29%
cases:5.62%
controls:0.40%
—
—
cases:6.22%
controls:0.36%
cases:14.75%
controls:1.17%
cases:24.08%
controls:3.85%
104
109
394
4863
71
64
427
4908
28
20
470
4952
—
31
18
467
4954
73
58
422
4899
118
189
372
4725
sertraline; oral
N06AB06 [21604714]
2.5e+00
2.5e+00
2.4e+00
—
2.9e+00
2.6e+00
2.2e+00
cases:8.03%
controls:0.68%
cases:6.63%
controls:0.56%
cases:2.21%
controls:0.20%
—
—
cases:2.21%
controls:0.12%
cases:8.69%
controls:0.69%
cases:13.67%
controls:1.69%
40
34
458
4938
33
28
465
4944
11
10
487
4962
—
11
6
487
4966
43
34
452
4923
67
83
423
4831
clonazepam; oral, parenteral
N03AE01 [21604415]
2.8e+00
3.1e+00
—
—
3.4e+00
3.1e+00
2.6e+00
cases:7.63%
controls:0.52%
cases:6.43%
controls:0.30%
—
—
—
—
cases:3.01%
controls:0.10%
cases:7.27%
controls:0.36%
cases:9.59%
controls:0.81%
38
26
460
4946
32
15
466
4957
—
—
15
5
483
4967
36
18
459
4939
47
40
443
4874
quetiapine; oral
N05AH04 [21604544]
2.1e+00
2.1e+00
2.4e+00
—
2.4e+00
2.7e+00
3.1e+00
cases:3.61%
controls:0.44%
cases:3.01%
controls:0.36%
cases:1.81%
controls:0.16%
—
—
cases:1.61%
controls:0.14%
cases:6.26%
controls:0.46%
cases:16.94%
controls:0.96%
18
22
480
4950
15
18
483
4954
9
8
489
4964
—
8
7
490
4965
31
23
464
4934
83
47
407
4867
disulfiram; oral
N07BB01 [21604821]
3.4e+00
3.3e+00
—
—
1.0e+50
4.1e+00
3.9e+00
cases:8.03%
controls:0.30%
cases:5.42%
controls:0.20%
—
—
—
—
cases:3.21%
controls:0.00%
cases:6.67%
controls:0.12%
cases:15.71%
controls:0.37%
40
15
458
4957
27
10
471
4962
—
—
16
0
482
4972
33
6
462
4951
77
18
413
4896
Depressive episode, unspecified
F32.9 [45571760]
3.5e+00
3.9e+00
—
1.0e+50
—
4.3e+00
3.0e+00
cases:9.44%
controls:0.32%
cases:10.44%
controls:0.24%
—
—
cases:7.23%
controls:0.00%
—
—
cases:10.91%
controls:0.16%
cases:17.35%
controls:1.02%
47
16
451
4956
52
12
446
4960
—
36
0
462
4972
—
54
8
441
4949
85
50
405
4864
mirtazapine; oral
N06AX11 [21604740]
2.6e+00
2.9e+00
3.4e+00
—
—
3.2e+00
2.4e+00
cases:11.24%
controls:0.91%
cases:11.04%
controls:0.66%
cases:4.02%
controls:0.14%
—
—
—
—
cases:15.56%
controls:0.73%
cases:23.67%
controls:2.83%
56
45
442
4927
55
33
443
4939
20
7
478
4965
—
—
77
36
418
4921
116
139
374
4775
Emergency Room Visit
ER [9203]
1.3e+00
2.3e+00
3.0e+00
—
3.6e+00
2.4e+00
2.0e+00
cases:30.92%
controls:10.52%
cases:45.78%
controls:8.13%
cases:19.48%
controls:1.21%
—
—
cases:24.90%
controls:0.93%
cases:55.56%
controls:10.05%
cases:74.90%
controls:29.55%
154
523
344
4449
228
404
270
4568
97
60
401
4912
—
124
46
374
4926
275
498
220
4459
367
1452
123
3462
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
3.4e+00
3.5e+00
—
1.0e+50
—
4.6e+00
2.8e+00
cases:8.03%
controls:0.28%
cases:7.03%
controls:0.22%
—
—
cases:3.01%
controls:0.00%
—
—
cases:8.89%
controls:0.10%
cases:8.78%
controls:0.57%
40
14
458
4958
35
11
463
4961
—
15
0
483
4972
—
44
5
451
4952
43
28
447
4886
alprazolam; oral
N05BA12 [21604577]
2.1e+00
2.5e+00
3.0e+00
—
2.2e+00
2.4e+00
2.0e+00
cases:11.24%
controls:1.47%
cases:7.83%
controls:0.68%
cases:3.41%
controls:0.18%
—
—
cases:2.41%
controls:0.26%
cases:6.67%
controls:0.67%
cases:10.00%
controls:1.49%
56
73
442
4899
39
34
459
4938
17
9
481
4963
—
12
13
486
4959
33
33
462
4924
49
73
441
4841
Inpatient Hospital
21 [8717]
1.4e+00
2.2e+00
2.8e+00
—
3.7e+00
2.3e+00
1.8e+00
cases:66.06%
controls:32.96%
cases:50.80%
controls:10.70%
cases:16.87%
controls:1.27%
—
—
cases:34.54%
controls:1.35%
cases:55.15%
controls:10.71%
cases:73.06%
controls:30.14%
329
1639
169
3333
253
532
245
4440
84
63
414
4909
—
172
67
326
4905
273
531
222
4426
358
1481
132
3433
perphenazine; oral, parenteral, rectal
N05AB03 [21604502]
3.3e+00
3.0e+00
2.5e+00
—
—
2.7e+00
2.6e+00
cases:7.83%
controls:0.32%
cases:5.02%
controls:0.26%
cases:1.41%
controls:0.12%
—
—
—
—
cases:4.24%
controls:0.30%
cases:5.10%
controls:0.39%
39
16
459
4956
25
13
473
4959
7
6
491
4966
—
—
21
15
474
4942
25
19
465
4895
General Practice
1 [38004446]
1.8e+00
2.3e+00
2.6e+00
1.0e+50
3.1e+00
2.3e+00
1.9e+00
cases:20.48%
controls:4.18%
cases:13.65%
controls:1.57%
cases:3.61%
controls:0.28%
cases:4.62%
controls:0.00%
cases:4.82%
controls:0.22%
cases:14.55%
controls:1.69%
cases:26.73%
controls:4.95%
102
208
396
4764
68
78
430
4894
18
14
480
4958
23
0
475
4972
24
11
474
4961
72
84
423
4873
131
243
359
4671
Severe psychotic and other severe mental disorders
112 [2001600112]
3.5e+00
3.6e+00
—
—
—
3.6e+00
3.1e+00
cases:8.23%
controls:0.28%
cases:4.22%
controls:0.12%
—
—
—
—
—
—
cases:4.24%
controls:0.12%
cases:11.63%
controls:0.59%
41
14
457
4958
21
6
477
4966
—
—
—
21
6
474
4951
57
29
433
4885
buspirone; oral
N05BE01 [21604601]
3.5e+00
3.0e+00
—
—
—
3.6e+00
3.1e+00
cases:6.83%
controls:0.22%
cases:2.01%
controls:0.10%
—
—
—
—
—
—
cases:3.43%
controls:0.10%
cases:5.31%
controls:0.24%
34
11
464
4961
10
5
488
4967
—
—
—
17
5
478
4952
26
12
464
4902
Office Visit
OMOP4822458 [581477]
1.4e+00
1.9e+00
2.0e+00
—
4.0e+00
2.0e+00
1.8e+00
cases:11.24%
controls:3.12%
cases:14.46%
controls:2.39%
cases:2.41%
controls:0.34%
—
—
cases:13.86%
controls:0.30%
cases:16.77%
controls:2.54%
cases:32.24%
controls:7.33%
56
155
442
4817
72
119
426
4853
12
17
486
4955
—
69
15
429
4957
83
126
412
4831
158
360
332
4554
propranolol; oral, parenteral
C07AA05 [21601670]
1.5e+00
1.7e+00
2.7e+00
—
2.9e+00
2.1e+00
2.0e+00
cases:8.23%
controls:1.93%
cases:5.62%
controls:1.03%
cases:2.81%
controls:0.20%
—
—
cases:1.81%
controls:0.10%
cases:6.87%
controls:0.89%
cases:14.69%
controls:2.20%
41
96
457
4876
28
51
470
4921
14
10
484
4962
—
9
5
489
4967
34
44
461
4913
72
108
418
4806
fluvoxamine; oral
N06AB08 [21604716]
3.3e+00
3.6e+00
—
—
—
3.6e+00
2.3e+00
cases:6.22%
controls:0.24%
cases:3.41%
controls:0.10%
—
—
—
—
—
—
cases:5.05%
controls:0.14%
cases:4.08%
controls:0.41%
31
12
467
4960
17
5
481
4967
—
—
—
25
7
470
4950
20
20
470
4894
chlordiazepoxide; oral, parenteral
N05BA02 [21604567]
3.3e+00
3.3e+00
—
—
—
2.9e+00
3.2e+00
cases:5.82%
controls:0.22%
cases:2.61%
controls:0.10%
—
—
—
—
—
—
cases:2.63%
controls:0.14%
cases:5.51%
controls:0.24%
29
11
469
4961
13
5
485
4967
—
—
—
13
7
482
4950
27
12
463
4902
haloperidol; oral, parenteral
N05AD01 [21604516]
3.3e+00
3.4e+00
—
—
—
3.1e+00
2.9e+00
cases:4.02%
controls:0.16%
cases:3.01%
controls:0.10%
—
—
—
—
—
—
cases:2.22%
controls:0.10%
cases:4.29%
controls:0.24%
20
8
478
4964
15
5
483
4967
—
—
—
11
5
484
4952
21
12
469
4902
thioridazine; oral
N05AC02 [21604512]
3.1e+00
3.1e+00
—
—
—
3.1e+00
3.3e+00
cases:6.02%
controls:0.28%
cases:3.01%
controls:0.14%
—
—
—
—
—
—
cases:3.03%
controls:0.14%
cases:2.65%
controls:0.10%
30
14
468
4958
15
7
483
4965
—
—
—
15
7
480
4950
13
5
477
4909
mianserin; oral
N06AX03 [21604732]
3.1e+00
3.3e+00
—
—
—
3.1e+00
3.0e+00
cases:10.04%
controls:0.50%
cases:5.22%
controls:0.20%
—
—
—
—
—
—
cases:4.24%
controls:0.20%
cases:6.53%
controls:0.35%
50
25
448
4947
26
10
472
4962
—
—
—
21
10
474
4947
32
17
458
4897
risperidone; oral, parenteral
N05AX08 [21604559]
3.0e+00
2.9e+00
—
—
—
3.6e+00
2.9e+00
cases:5.02%
controls:0.26%
cases:3.61%
controls:0.20%
—
—
—
—
—
—
cases:7.47%
controls:0.22%
cases:13.06%
controls:0.81%
25
13
473
4959
18
10
480
4962
—
—
—
37
11
458
4946
64
40
426
4874
Unspecified nonorganic psychosis
F29 [45533099]
2.3e+00
3.6e+00
—
—
—
3.5e+00
3.0e+00
cases:1.81%
controls:0.18%
cases:5.42%
controls:0.16%
—
—
—
—
—
—
cases:5.05%
controls:0.16%
cases:8.98%
controls:0.49%
9
9
489
4963
27
8
471
4964
—
—
—
25
8
470
4949
44
24
446
4890
clozapine; oral, parenteral
N05AH02 [21604542]
—
2.5e+00
2.5e+00
—
—
3.3e+00
4.0e+00
—
—
cases:1.41%
controls:0.12%
cases:1.20%
controls:0.10%
—
—
—
—
cases:3.23%
controls:0.12%
cases:9.18%
controls:0.18%
—
7
6
491
4966
6
5
492
4967
—
—
16
6
479
4951
45
9
445
4905
carbamazepine; oral, rectal
N03AF01 [21604417]
2.4e+00
2.8e+00
—
—
2.3e+00
2.4e+00
2.4e+00
cases:6.43%
controls:0.64%
cases:5.22%
controls:0.34%
—
—
—
—
cases:1.20%
controls:0.12%
cases:3.23%
controls:0.30%
cases:6.12%
controls:0.61%
32
32
466
4940
26
17
472
4955
—
—
6
6
492
4966
16
15
479
4942
30
30
460
4884
Mixed anxiety and depressive disorder
F41.2 [45566845]
3.0e+00
3.2e+00
—
—
—
3.4e+00
2.5e+00
cases:3.41%
controls:0.18%
cases:3.01%
controls:0.12%
—
—
—
—
—
—
cases:3.03%
controls:0.10%
cases:6.94%
controls:0.63%
17
9
481
4963
15
6
483
4966
—
—
—
15
5
480
4952
34
31
456
4883
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
2.4e+00
3.2e+00
—
1.0e+50
—
3.2e+00
3.2e+00
cases:2.81%
controls:0.26%
cases:4.22%
controls:0.18%
—
—
cases:2.01%
controls:0.00%
—
—
cases:6.46%
controls:0.28%
cases:7.96%
controls:0.35%
14
13
484
4959
21
9
477
4963
—
10
0
488
4972
—
32
14
463
4943
39
17
451
4897
Anxiety disorder, unspecified
F41.9 [45542849]
2.6e+00
3.0e+00
—
—
—
2.9e+00
2.7e+00
cases:2.61%
controls:0.20%
cases:2.01%
controls:0.10%
—
—
—
—
—
—
cases:2.83%
controls:0.16%
cases:6.12%
controls:0.45%
13
10
485
4962
10
5
488
4967
—
—
—
14
8
481
4949
30
22
460
4892
lithium; oral
N05AN01 [21604556]
—
3.6e+00
1.0e+50
—
—
3.6e+00
3.9e+00
—
—
cases:4.22%
controls:0.12%
cases:1.20%
controls:0.00%
—
—
—
—
cases:4.44%
controls:0.12%
cases:7.35%
controls:0.16%
—
21
6
477
4966
6
0
492
4972
—
—
22
6
473
4951
36
8
454
4906
Internal Medicine
11 [38004456]
1.3e+00
1.4e+00
2.3e+00
—
2.6e+00
1.7e+00
1.6e+00
cases:33.94%
controls:11.77%
cases:26.71%
controls:8.27%
cases:12.85%
controls:1.51%
—
—
cases:16.87%
controls:1.43%
cases:37.58%
controls:9.54%
cases:55.71%
controls:19.74%
169
585
329
4387
133
411
365
4561
64
75
434
4897
—
84
71
414
4901
186
473
309
4484
273
970
217
3944
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
1.9e+00
3.1e+00
—
—
—
3.2e+00
2.8e+00
cases:3.61%
controls:0.58%
cases:4.22%
controls:0.20%
—
—
—
—
—
—
cases:2.83%
controls:0.12%
cases:3.67%
controls:0.22%
18
29
480
4943
21
10
477
4962
—
—
—
14
6
481
4951
18
11
472
4903
venlafaxine; oral
N06AX16 [21604745]
2.5e+00
2.8e+00
—
—
—
3.2e+00
2.4e+00
cases:4.22%
controls:0.36%
cases:4.02%
controls:0.26%
—
—
—
—
—
—
cases:6.06%
controls:0.26%
cases:13.06%
controls:1.40%
21
18
477
4954
20
13
478
4959
—
—
—
30
13
465
4944
64
69
426
4845
trimipramine; oral, parenteral
N06AA06 [21604693]
3.4e+00
2.3e+00
—
—
—
2.3e+00
2.6e+00
cases:4.62%
controls:0.16%
cases:1.20%
controls:0.12%
—
—
—
—
—
—
cases:1.82%
controls:0.18%
cases:2.65%
controls:0.20%
23
8
475
4964
6
6
492
4966
—
—
—
9
9
486
4948
13
10
477
4904
nitrazepam; oral
N05CD02 [21604637]
3.4e+00
2.3e+00
—
—
—
2.2e+00
2.5e+00
cases:4.02%
controls:0.14%
cases:1.41%
controls:0.14%
—
—
—
—
—
—
cases:1.41%
controls:0.16%
cases:2.24%
controls:0.18%
20
7
478
4965
7
7
491
4965
—
—
—
7
8
488
4949
11
9
479
4905
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
—
3.1e+00
—
—
—
3.5e+00
3.5e+00
—
—
cases:2.61%
controls:0.12%
—
—
—
—
—
—
cases:4.04%
controls:0.12%
cases:6.94%
controls:0.22%
—
13
6
485
4966
—
—
—
20
6
475
4951
34
11
456
4903
Other and unspecified convulsions
R56.8 [45602033]
2.2e+00
2.4e+00
—
—
—
2.5e+00
2.8e+00
cases:1.61%
controls:0.18%
cases:1.61%
controls:0.14%
—
—
—
—
—
—
cases:1.62%
controls:0.14%
cases:6.94%
controls:0.45%
8
9
490
4963
8
7
490
4965
—
—
—
8
7
487
4950
34
22
456
4892
doxepin; oral, parenteral
N06AA12 [21604699]
2.5e+00
2.5e+00
—
—
—
2.0e+00
2.7e+00
cases:6.22%
controls:0.56%
cases:4.42%
controls:0.36%
—
—
—
—
—
—
cases:2.83%
controls:0.38%
cases:7.14%
controls:0.53%
31
28
467
4944
22
18
476
4954
—
—
—
14
19
481
4938
35
26
455
4888
lorazepam; oral, parenteral, sublingual
N05BA06 [21604571]
1.9e+00
2.7e+00
—
—
—
2.6e+00
2.5e+00
cases:2.41%
controls:0.38%
cases:3.61%
controls:0.24%
—
—
—
—
—
—
cases:3.43%
controls:0.26%
cases:7.14%
controls:0.65%
12
19
486
4953
18
12
480
4960
—
—
—
17
13
478
4944
35
32
455
4882
Pharmacy visit
OMOP4822462 [581458]
8.1e-01
1.5e+00
1.5e+00
1.7e+00
1.5e+00
1.5e+00
1.2e+00
cases:93.98%
controls:87.39%
cases:88.76%
controls:64.90%
cases:57.03%
controls:22.12%
cases:4.02%
controls:0.72%
cases:54.62%
controls:21.94%
cases:89.29%
controls:66.15%
cases:96.12%
controls:88.22%
468
4345
30
627
442
3227
56
1745
284
1100
214
3872
20
36
478
4936
272
1091
226
3881
442
3279
53
1678
471
4335
19
579
Severe depressive episode with psychotic symptoms
F32.3 [45600739]
3.2e+00
—
—
1.0e+50
—
3.4e+00
2.8e+00
cases:2.81%
controls:0.12%
—
—
—
—
cases:1.20%
controls:0.00%
—
—
cases:3.64%
controls:0.12%
cases:3.27%
controls:0.20%
14
6
484
4966
—
—
6
0
492
4972
—
18
6
477
4951
16
10
474
4904
zolpidem; oral
N05CF02 [21604655]
1.1e+00
2.1e+00
2.5e+00
—
—
2.3e+00
2.5e+00
cases:1.00%
controls:0.32%
cases:1.61%
controls:0.20%
cases:1.20%
controls:0.10%
—
—
—
—
cases:2.42%
controls:0.24%
cases:8.78%
controls:0.79%
5
16
493
4956
8
10
490
4962
6
5
492
4967
—
—
12
12
483
4945
43
39
447
4875
ECG with 12 standard connections
XF400 [2001303368]
1.6e+00
2.6e+00
1.0e+50
—
—
2.9e+00
2.2e+00
cases:1.81%
controls:0.38%
cases:3.82%
controls:0.30%
cases:1.61%
controls:0.00%
—
—
—
—
cases:6.46%
controls:0.38%
cases:13.27%
controls:1.59%
9
19
489
4953
19
15
479
4957
8
0
490
4972
—
—
32
19
463
4938
65
78
425
4836
paroxetine; oral
N06AB05 [21604713]
2.5e+00
2.2e+00
—
—
—
2.5e+00
1.8e+00
cases:4.82%
controls:0.40%
cases:2.01%
controls:0.22%
—
—
—
—
—
—
cases:3.03%
controls:0.26%
cases:9.80%
controls:1.69%
24
20
474
4952
10
11
488
4961
—
—
—
15
13
480
4944
48
83
442
4831
Outpatient Visit
OP [9202]
4.4e-01
9.8e-01
1.5e+00
2.2e+00
1.6e+00
1.0e+00
9.9e-01
cases:35.94%
controls:26.63%
cases:48.19%
controls:25.86%
cases:21.69%
controls:5.97%
cases:2.01%
controls:0.22%
cases:24.70%
controls:5.97%
cases:52.53%
controls:27.92%
cases:77.55%
controls:56.19%
179
1324
319
3648
240
1286
258
3686
108
297
390
4675
10
11
488
4961
123
297
375
4675
260
1384
235
3573
380
2761
110
2153
moclobemide; oral
N06AG02 [21604727]
2.1e+00
2.4e+00
—
—
—
2.1e+00
2.0e+00
cases:5.82%
controls:0.74%
cases:2.61%
controls:0.24%
—
—
—
—
—
—
cases:1.82%
controls:0.22%
cases:2.86%
controls:0.39%
29
37
469
4935
13
12
485
4960
—
—
—
9
11
486
4946
14
19
476
4895
Outpatient Hospital
22 [8756]
9.6e-01
1.2e+00
1.5e+00
—
2.1e+00
1.6e+00
1.0e+00
cases:39.96%
controls:20.23%
cases:19.28%
controls:6.88%
cases:2.81%
controls:0.62%
—
—
cases:6.83%
controls:0.91%
cases:24.44%
controls:6.35%
cases:42.24%
controls:21.08%
199
1006
299
3966
96
342
402
4630
14
31
484
4941
—
34
45
464
4927
121
315
374
4642
207
1036
283
3878
hydroxyzine; oral, parenteral
N05BB01 [21604590]
1.2e+00
2.0e+00
—
—
—
2.9e+00
2.2e+00
cases:5.22%
controls:1.69%
cases:3.21%
controls:0.44%
—
—
—
—
—
—
cases:4.04%
controls:0.24%
cases:2.65%
controls:0.31%
26
84
472
4888
16
22
482
4950
—
—
—
20
12
475
4945
13
15
477
4899
amitriptyline and psycholeptics
N06CA01 [21604789]
1.3e+00
1.6e+00
2.4e+00
—
—
1.7e+00
1.1e+00
cases:5.02%
controls:1.43%
cases:3.61%
controls:0.76%
cases:1.61%
controls:0.14%
—
—
—
—
cases:3.64%
controls:0.69%
cases:4.08%
controls:1.36%
25
71
473
4901
18
38
480
4934
8
7
490
4965
—
—
18
34
477
4923
20
67
470
4847
Addiction caused by alcohol UNS
F10.29 [2000501684]
—
—
1.0e+50
1.0e+50
1.0e+50
4.1e+00
4.0e+00
—
—
—
—
cases:1.00%
controls:0.00%
cases:1.41%
controls:0.00%
cases:3.01%
controls:0.00%
cases:5.86%
controls:0.10%
cases:9.80%
controls:0.20%
—
—
5
0
493
4972
7
0
491
4972
15
0
483
4972
29
5
466
4952
48
10
442
4904
Neurology
13 [38004458]
1.0e+00
1.4e+00
2.4e+00
1.0e+50
1.4e+00
1.5e+00
1.5e+00
cases:8.43%
controls:3.18%
cases:7.03%
controls:1.85%
cases:2.61%
controls:0.24%
cases:1.20%
controls:0.00%
cases:1.81%
controls:0.44%
cases:8.48%
controls:1.98%
cases:23.06%
controls:6.31%
42
158
456
4814
35
92
463
4880
13
12
485
4960
6
0
492
4972
9
22
489
4950
42
98
453
4859
113
310
377
4604
Epilepsy, unspecified
G40.9 [45562083]
1.6e+00
2.3e+00
—
—
—
2.4e+00
2.9e+00
cases:1.20%
controls:0.24%
cases:1.61%
controls:0.16%
—
—
—
—
—
—
cases:1.82%
controls:0.16%
cases:4.08%
controls:0.24%
6
12
492
4960
8
8
490
4964
—
—
—
9
8
486
4949
20
12
470
4902
Poisoning by systemic antibiotics
T36 [45756588]
2.7e+00
—
1.0e+50
1.0e+50
1.0e+50
—
4.5e+00
cases:2.01%
controls:0.14%
—
—
cases:5.62%
controls:0.00%
cases:98.59%
controls:0.00%
cases:14.06%
controls:0.00%
—
—
cases:31.02%
controls:0.49%
10
7
488
4965
—
28
0
470
4972
491
0
7
4972
70
0
428
4972
—
152
24
338
4890
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
2.8e+00
—
1.0e+50
1.0e+50
1.0e+50
—
4.4e+00
cases:2.21%
controls:0.14%
—
—
cases:3.21%
controls:0.00%
cases:40.76%
controls:0.00%
cases:8.43%
controls:0.00%
—
—
cases:22.24%
controls:0.35%
11
7
487
4965
—
16
0
482
4972
203
0
295
4972
42
0
456
4972
—
109
17
381
4897
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 [45547705]
—
3.7e+00
—
1.0e+50
—
—
3.4e+00
—
—
cases:4.02%
controls:0.10%
—
—
cases:1.61%
controls:0.00%
—
—
—
—
cases:9.80%
controls:0.37%
—
20
5
478
4967
—
8
0
490
4972
—
—
48
18
442
4896
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
1.3e+00
2.7e+00
—
—
—
2.4e+00
1.8e+00
cases:1.41%
controls:0.40%
cases:2.41%
controls:0.16%
—
—
—
—
—
—
cases:2.22%
controls:0.20%
cases:4.90%
controls:0.81%
7
20
491
4952
12
8
486
4964
—
—
—
11
10
484
4947
24
40
466
4874
Concussion
S06.0 [45582805]
1.9e+00
—
—
—
—
2.9e+00
2.1e+00
cases:2.01%
controls:0.30%
—
—
—
—
—
—
—
—
cases:1.82%
controls:0.10%
cases:4.69%
controls:0.61%
10
15
488
4957
—
—
—
—
9
5
486
4952
23
30
467
4884
biperiden; oral, parenteral
N04AA02 [21604447]
3.1e+00
—
—
—
—
—
3.8e+00
cases:2.61%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:4.29%
controls:0.10%
13
6
485
4966
—
—
—
—
—
21
5
469
4909
Medical doctor
Z2221 [2001311556]
1.1e+00
1.6e+00
—
1.0e+50
—
2.0e+00
1.9e+00
cases:2.61%
controls:0.84%
cases:1.61%
controls:0.32%
—
—
cases:1.41%
controls:0.00%
—
—
cases:1.62%
controls:0.22%
cases:2.86%
controls:0.45%
13
42
485
4930
8
16
490
4956
—
7
0
491
4972
—
8
11
487
4946
14
22
476
4892
amitriptyline; oral, parenteral
N06AA09 [21604696]
1.6e+00
1.8e+00
—
—
—
1.9e+00
1.3e+00
cases:5.22%
controls:1.15%
cases:3.61%
controls:0.62%
—
—
—
—
—
—
cases:3.23%
controls:0.50%
cases:6.33%
controls:1.73%
26
57
472
4915
18
31
480
4941
—
—
—
16
25
479
4932
31
85
459
4829
General Surgery
2 [38004447]
9.5e-01
1.2e+00
9.8e-01
—
1.1e+00
1.4e+00
9.1e-01
cases:30.52%
controls:14.54%
cases:20.48%
controls:7.52%
cases:3.21%
controls:1.23%
—
—
cases:3.61%
controls:1.25%
cases:24.04%
controls:7.44%
cases:40.00%
controls:21.14%
152
723
346
4249
102
374
396
4598
16
61
482
4911
—
18
62
480
4910
119
369
376
4588
196
1039
294
3875
trazodone; oral
N06AX05 [21604734]
3.0e+00
1.0e+50
—
—
—
2.3e+00
3.2e+00
cases:2.01%
controls:0.10%
cases:1.00%
controls:0.00%
—
—
—
—
—
—
cases:1.01%
controls:0.10%
cases:3.47%
controls:0.14%
10
5
488
4967
5
0
493
4972
—
—
—
5
5
490
4952
17
7
473
4907
Other and unspecified abdominal pain
R10.4 [45568113]
1.2e+00
1.6e+00
—
—
—
1.9e+00
1.5e+00
cases:5.82%
controls:1.83%
cases:4.42%
controls:0.91%
—
—
—
—
—
—
cases:6.46%
controls:1.05%
cases:14.90%
controls:3.83%
29
91
469
4881
22
45
476
4927
—
—
—
32
52
463
4905
73
188
417
4726
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
-1.0e+50
1.2e+00
—
1.0e+50
3.3e+00
1.5e+00
1.2e+00
cases:0.00%
controls:0.38%
cases:1.41%
controls:0.44%
—
—
cases:1.00%
controls:0.00%
cases:2.61%
controls:0.10%
cases:3.84%
controls:0.87%
cases:8.78%
controls:2.93%
0
19
498
4953
7
22
491
4950
—
5
0
493
4972
13
5
485
4967
19
43
476
4914
43
144
447
4770
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
-1.0e+50
2.2e+00
—
—
1.0e+50
2.4e+00
1.3e+00
cases:0.00%
controls:0.10%
cases:1.41%
controls:0.16%
—
—
—
—
cases:1.61%
controls:0.00%
cases:3.03%
controls:0.28%
cases:5.10%
controls:1.47%
0
5
498
4967
7
8
491
4964
—
—
8
0
490
4972
15
14
480
4943
25
72
465
4842
flupentixol; oral, parenteral
N05AF01 [21604531]
2.9e+00
—
—
—
—
2.9e+00
—
cases:5.02%
controls:0.30%
—
—
—
—
—
—
—
—
cases:1.82%
controls:0.10%
—
—
25
15
473
4957
—
—
—
—
9
5
486
4952
—
Upper gastrointestinal surgery
106 [44777669]
7.8e-01
2.0e+00
—
—
—
2.2e+00
1.1e+00
cases:2.81%
controls:1.31%
cases:3.21%
controls:0.46%
—
—
—
—
—
—
cases:4.04%
controls:0.46%
cases:8.98%
controls:3.17%
14
65
484
4907
16
23
482
4949
—
—
—
20
23
475
4934
44
156
446
4758
midazolam; nasal, oral, parenteral, sublingual
N05CD08 [21604643]
2.9e+00
—
—
—
—
2.3e+00
—
cases:3.21%
controls:0.18%
—
—
—
—
—
—
—
—
cases:1.41%
controls:0.14%
—
—
16
9
482
4963
—
—
—
—
7
7
488
4950
—
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
—
1.3e+00
1.5e+00
—
2.8e+00
1.1e+00
4.6e-01
—
—
cases:3.21%
controls:0.88%
cases:1.41%
controls:0.32%
—
—
cases:2.81%
controls:0.18%
cases:4.65%
controls:1.55%
cases:8.37%
controls:5.47%
—
16
44
482
4928
7
16
491
4956
—
14
9
484
4963
23
77
472
4880
41
269
449
4645
Constipation
K59.0 [45557663]
2.3e+00
—
—
—
—
—
2.8e+00
cases:1.20%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:2.04%
controls:0.12%
6
6
492
4966
—
—
—
—
—
10
6
480
4908
Hospital outpatient
ZY010 [2001311599]
—
—
—
—
1.0e+50
2.6e+00
2.5e+00
—
—
—
—
—
—
—
—
cases:1.81%
controls:0.00%
cases:2.22%
controls:0.16%
cases:2.65%
controls:0.22%
—
—
—
—
9
0
489
4972
11
8
484
4949
13
11
477
4903
Open wound of scalp
S01.0 [45592468]
3.1e+00
1.0e+50
—
—
—
—
1.9e+00
cases:2.21%
controls:0.10%
cases:1.00%
controls:0.00%
—
—
—
—
—
—
—
—
cases:3.06%
controls:0.47%
11
5
487
4967
5
0
493
4972
—
—
—
—
15
23
475
4891
reboxetine; oral
N06AX18 [21604747]
—
—
—
—
—
2.6e+00
2.4e+00
—
—
—
—
—
—
—
—
—
—
cases:1.82%
controls:0.14%
cases:1.84%
controls:0.16%
—
—
—
—
—
9
7
486
4950
9
8
481
4906
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
1.1e+00
1.2e+00
1.6e+00
—
—
1.3e+00
1.4e+00
cases:6.83%
controls:2.41%
cases:4.02%
controls:1.25%
cases:1.20%
controls:0.24%
—
—
—
—
cases:4.85%
controls:1.39%
cases:15.10%
controls:4.38%
34
120
464
4852
20
62
478
4910
6
12
492
4960
—
—
24
69
471
4888
74
215
416
4699
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
7.1e-01
1.7e+00
—
—
—
1.8e+00
1.3e+00
cases:3.61%
controls:1.81%
cases:3.21%
controls:0.58%
—
—
—
—
—
—
cases:2.63%
controls:0.42%
cases:6.33%
controls:1.79%
18
90
480
4882
16
29
482
4943
—
—
—
13
21
482
4936
31
88
459
4826
other preparations, combinations; ointment
C05AX03 [21601631]
1.1e+00
1.4e+00
—
—
—
1.4e+00
8.3e-01
cases:6.02%
controls:2.07%
cases:2.21%
controls:0.56%
—
—
—
—
—
—
cases:2.02%
controls:0.50%
cases:4.49%
controls:2.01%
30
103
468
4869
11
28
487
4944
—
—
—
10
25
485
4932
22
99
468
4815
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
-1.0e+50
1.8e+00
—
—
—
1.8e+00
1.1e+00
cases:0.00%
controls:0.24%
cases:2.61%
controls:0.42%
—
—
—
—
—
—
cases:3.23%
controls:0.56%
cases:8.37%
controls:2.97%
0
12
498
4960
13
21
485
4951
—
—
—
16
28
479
4929
41
146
449
4768
Chest pain, unspecified
R07.4 [45558450]
1.4e+00
1.8e+00
—
—
—
1.0e+00
1.5e+00
cases:2.21%
controls:0.56%
cases:2.01%
controls:0.32%
—
—
—
—
—
—
cases:1.41%
controls:0.52%
cases:5.51%
controls:1.34%
11
28
487
4944
10
16
488
4956
—
—
—
7
26
488
4931
27
66
463
4848
Emotionally unstable personality disorder, borderline condition
F60.31 [2000502023]
—
—
1.0e+50
1.0e+50
1.0e+50
—
4.6e+00
—
—
—
—
cases:2.21%
controls:0.00%
cases:1.61%
controls:0.00%
cases:3.41%
controls:0.00%
—
—
cases:11.22%
controls:0.12%
—
—
11
0
487
4972
8
0
490
4972
17
0
481
4972
—
55
6
435
4908
Case Management Agency
251B00000X [38004193]
6.5e-01
6.3e-01
9.6e-01
—
8.6e-01
7.1e-01
8.1e-01
cases:23.49%
controls:13.76%
cases:16.67%
controls:9.59%
cases:6.02%
controls:2.39%
—
—
cases:6.22%
controls:2.74%
cases:17.98%
controls:9.74%
cases:34.49%
controls:18.93%
117
684
381
4288
83
477
415
4495
30
119
468
4853
—
31
136
467
4836
89
483
406
4474
169
930
321
3984
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
1.0e+50
4.6e+00
—
—
cases:3.41%
controls:0.00%
cases:1.61%
controls:0.00%
cases:1.61%
controls:0.00%
cases:2.41%
controls:0.00%
cases:6.46%
controls:0.00%
cases:11.02%
controls:0.12%
—
17
0
481
4972
8
0
490
4972
8
0
490
4972
12
0
486
4972
32
0
463
4957
54
6
436
4908
Mixed personality disorders
F61.0 [2000502024]
—
—
—
1.0e+50
1.0e+50
—
4.5e+00
—
—
—
—
—
—
cases:1.20%
controls:0.00%
cases:2.61%
controls:0.00%
—
—
cases:8.78%
controls:0.10%
—
—
—
6
0
492
4972
13
0
485
4972
—
43
5
447
4909
Alcohol dependence currently independent
F10.20 [2000501677]
—
—
—
1.0e+50
1.0e+50
1.0e+50
4.5e+00
—
—
—
—
—
—
cases:1.00%
controls:0.00%
cases:1.61%
controls:0.00%
cases:2.42%
controls:0.00%
cases:8.78%
controls:0.10%
—
—
—
5
0
493
4972
8
0
490
4972
12
0
483
4957
43
5
447
4909
Nonorganic insomnia
F51.0 [45552492]
2.3e+00
—
—
—
—
—
2.2e+00
cases:1.20%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:2.04%
controls:0.22%
6
6
492
4966
—
—
—
—
—
10
11
480
4903
Orthopedic Surgery
20 [38004465]
9.8e-01
1.2e+00
—
—
—
1.3e+00
1.0e+00
cases:7.03%
controls:2.76%
cases:3.21%
controls:1.01%
—
—
—
—
—
—
cases:4.65%
controls:1.27%
cases:17.14%
controls:6.90%
35
137
463
4835
16
50
482
4922
—
—
—
23
63
472
4894
84
339
406
4575
ranitidine; oral, parenteral
A02BA02 [21600083]
9.1e-01
1.2e+00
—
—
1.6e+00
1.3e+00
9.5e-01
cases:8.43%
controls:3.58%
cases:3.41%
controls:1.01%
—
—
—
—
cases:1.00%
controls:0.20%
cases:3.84%
controls:1.05%
cases:5.92%
controls:2.38%
42
178
456
4794
17
50
481
4922
—
—
5
10
493
4962
19
52
476
4905
29
117
461
4797
ranitidine bismuth citrate; oral
A02BA07 [21600088]
9.1e-01
1.2e+00
—
—
1.6e+00
1.3e+00
9.5e-01
cases:8.43%
controls:3.58%
cases:3.41%
controls:1.01%
—
—
—
—
cases:1.00%
controls:0.20%
cases:3.84%
controls:1.05%
cases:5.92%
controls:2.38%
42
178
456
4794
17
50
481
4922
—
—
5
10
493
4962
19
52
476
4905
29
117
461
4797
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
6.4e-01
8.2e-01
9.9e-01
—
1.3e+00
7.8e-01
7.7e-01
cases:26.91%
controls:16.23%
cases:15.46%
controls:7.48%
cases:2.41%
controls:0.91%
—
—
cases:2.81%
controls:0.76%
cases:14.55%
controls:7.26%
cases:38.16%
controls:22.20%
134
807
364
4165
77
372
421
4600
12
45
486
4927
—
14
38
484
4934
72
360
423
4597
187
1091
303
3823
ibuprofen
R02AX02 [1588667]
6.4e-01
8.2e-01
9.9e-01
—
1.3e+00
7.8e-01
7.7e-01
cases:26.91%
controls:16.23%
cases:15.46%
controls:7.48%
cases:2.41%
controls:0.91%
—
—
cases:2.81%
controls:0.76%
cases:14.55%
controls:7.26%
cases:38.16%
controls:22.20%
134
807
364
4165
77
372
421
4600
12
45
486
4927
—
14
38
484
4934
72
360
423
4597
187
1091
303
3823
cefalexin; oral
J01DB01 [21602870]
6.0e-01
6.8e-01
1.3e-01
—
1.7e+00
6.7e-01
7.2e-01
cases:35.74%
controls:23.43%
cases:14.26%
controls:7.78%
cases:1.00%
controls:0.88%
—
—
cases:3.01%
controls:0.58%
cases:13.74%
controls:7.57%
cases:43.27%
controls:27.07%
178
1165
320
3807
71
387
427
4585
5
44
493
4928
—
15
29
483
4943
68
375
427
4582
212
1330
278
3584
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
1.5e+00
1.7e+00
—
—
—
1.4e+00
1.1e+00
cases:2.41%
controls:0.54%
cases:1.81%
controls:0.34%
—
—
—
—
—
—
cases:1.41%
controls:0.36%
cases:5.92%
controls:1.99%
12
27
486
4945
9
17
489
4955
—
—
—
7
18
488
4939
29
98
461
4816
lansoprazole; oral
A02BC03 [21600098]
1.1e+00
1.2e+00
—
—
—
1.1e+00
9.0e-01
cases:5.62%
controls:1.91%
cases:3.41%
controls:1.11%
—
—
—
—
—
—
cases:2.83%
controls:0.93%
cases:8.37%
controls:3.58%
28
95
470
4877
17
55
481
4917
—
—
—
14
46
481
4911
41
176
449
4738
omeprazole; oral, parenteral
A02BC01 [21600096]
7.9e-01
1.4e+00
—
—
—
9.5e-01
1.1e+00
cases:5.22%
controls:2.43%
cases:4.62%
controls:1.19%
—
—
—
—
—
—
cases:3.64%
controls:1.43%
cases:8.37%
controls:3.09%
26
121
472
4851
23
59
475
4913
—
—
—
18
71
477
4886
41
152
449
4762
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
—
8.7e-01
9.2e-01
—
2.3e+00
1.0e+00
5.4e-01
—
—
cases:4.02%
controls:1.73%
cases:1.00%
controls:0.40%
—
—
cases:3.41%
controls:0.36%
cases:5.45%
controls:2.04%
cases:10.20%
controls:6.23%
—
20
86
478
4886
5
20
493
4952
—
17
18
481
4954
27
101
468
4856
50
306
440
4608
Recurrent depressive disorder, unspecified
F33.9 [45581458]
—
—
—
—
—
—
4.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:8.37%
controls:0.14%
—
—
—
—
—
—
41
7
449
4907
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
—
8.7e-01
8.7e-01
—
2.3e+00
1.0e+00
5.1e-01
—
—
cases:4.02%
controls:1.73%
cases:1.00%
controls:0.42%
—
—
cases:3.41%
controls:0.36%
cases:5.45%
controls:2.08%
cases:10.20%
controls:6.37%
—
20
86
478
4886
5
21
493
4951
—
17
18
481
4954
27
103
468
4854
50
313
440
4601
chlorpromazine; oral, parenteral, rectal
N05AA01 [21604492]
—
—
1.0e+50
—
—
—
4.0e+00
—
—
—
—
cases:2.01%
controls:0.00%
—
—
—
—
—
—
cases:6.33%
controls:0.12%
—
—
10
0
488
4972
—
—
—
31
6
459
4908
Alcohol-related acute intoxication uncomplicated
F10.00 [2000501668]
1.0e+50
1.0e+50
—
—
1.0e+50
—
4.0e+00
cases:1.20%
controls:0.00%
cases:2.81%
controls:0.00%
—
—
—
—
cases:1.20%
controls:0.00%
—
—
cases:7.14%
controls:0.14%
6
0
492
4972
14
0
484
4972
—
—
6
0
492
4972
—
35
7
455
4907
Emergency Medicine
93 [38004510]
—
1.6e+00
—
1.0e+50
—
1.3e+00
1.0e+00
—
—
cases:2.01%
controls:0.40%
—
—
cases:3.01%
controls:0.00%
—
—
cases:2.83%
controls:0.77%
cases:8.37%
controls:3.22%
—
10
20
488
4952
—
15
0
483
4972
—
14
38
481
4919
41
158
449
4756
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
—
8.2e-01
—
1.0e+50
2.9e+00
9.7e-01
3.9e-01
—
—
cases:3.01%
controls:1.35%
—
—
cases:1.20%
controls:0.00%
cases:2.81%
controls:0.16%
cases:5.25%
controls:2.06%
cases:9.59%
controls:6.72%
—
15
67
483
4905
—
6
0
492
4972
14
8
484
4964
26
102
469
4855
47
330
443
4584
naproxen; oral, rectal
M01AE02 [21603968]
5.9e-01
4.6e-01
—
—
1.7e+00
9.0e-01
6.6e-01
cases:21.89%
controls:13.48%
cases:6.63%
controls:4.28%
—
—
—
—
cases:2.61%
controls:0.50%
cases:9.09%
controls:3.89%
cases:14.69%
controls:8.18%
109
670
389
4302
33
213
465
4759
—
—
13
25
485
4947
45
193
450
4764
72
402
418
4512
naproxcinod
M01AE18 [40254094]
5.9e-01
4.6e-01
—
—
1.7e+00
9.0e-01
6.6e-01
cases:21.89%
controls:13.48%
cases:6.63%
controls:4.28%
—
—
—
—
cases:2.61%
controls:0.50%
cases:9.09%
controls:3.89%
cases:14.69%
controls:8.18%
109
670
389
4302
33
213
465
4759
—
—
13
25
485
4947
45
193
450
4764
72
402
418
4512
lactulose; oral
A06AD11 [21600571]
1.2e+00
1.7e+00
—
—
—
1.9e+00
1.9e+00
cases:2.21%
controls:0.66%
cases:1.41%
controls:0.26%
—
—
—
—
—
—
cases:1.62%
controls:0.24%
cases:5.10%
controls:0.79%
11
33
487
4939
7
13
491
4959
—
—
—
8
12
487
4945
25
39
465
4875
Alcohol dependence continuous use
F10.25 [2000501682]
—
—
—
—
—
—
3.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.29%
controls:0.10%
—
—
—
—
—
—
21
5
469
4909
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
F10.2 [45576496]
3.7e+00
—
—
—
—
—
—
cases:4.82%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
—
—
24
6
474
4966
—
—
—
—
—
—
Administration of medicine
SPAT1254 [2001700355]
1.5e+00
2.2e+00
—
—
—
—
9.6e-01
cases:1.81%
controls:0.40%
cases:1.81%
controls:0.20%
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.55%
9
20
489
4952
9
10
489
4962
—
—
—
—
7
27
483
4887
Bipolar affective disorder, unspecified
F31.9 [45571758]
—
1.0e+50
—
—
1.0e+50
—
3.7e+00
—
—
cases:1.41%
controls:0.00%
—
—
—
—
cases:1.81%
controls:0.00%
—
—
cases:5.51%
controls:0.14%
—
7
0
491
4972
—
—
9
0
489
4972
—
27
7
463
4907
Psychosis requiring demanding treatment
188 [2001600187]
—
—
—
—
—
—
3.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:6.73%
controls:0.18%
—
—
—
—
—
—
33
9
457
4905
Schizophrenia, unspecified
F20.9 [45576533]
—
—
—
1.0e+50
—
1.0e+50
3.7e+00
—
—
—
—
—
—
cases:1.00%
controls:0.00%
—
—
cases:1.41%
controls:0.00%
cases:5.31%
controls:0.14%
—
—
—
5
0
493
4972
—
7
0
488
4957
26
7
464
4907
General medical examination
Z00.0 [45585791]
6.2e-01
1.2e+00
—
—
—
2.3e+00
1.3e+00
cases:1.41%
controls:0.76%
cases:1.00%
controls:0.30%
—
—
—
—
—
—
cases:1.62%
controls:0.16%
cases:3.06%
controls:0.88%
7
38
491
4934
5
15
493
4957
—
—
—
8
8
487
4949
15
43
475
4871
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
1.8e+00
2.3e+00
—
—
—
—
1.8e+00
cases:1.41%
controls:0.24%
cases:1.00%
controls:0.10%
—
—
—
—
—
—
—
—
cases:3.47%
controls:0.61%
7
12
491
4960
5
5
493
4967
—
—
—
—
17
30
473
4884
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
7.3e-01
1.1e+00
1.5e+00
—
—
8.4e-01
8.7e-01
cases:10.24%
controls:5.19%
cases:6.22%
controls:2.21%
cases:1.81%
controls:0.42%
—
—
—
—
cases:6.67%
controls:2.99%
cases:16.33%
controls:7.53%
51
258
447
4714
31
110
467
4862
9
21
489
4951
—
—
33
148
462
4809
80
370
410
4544
Chronic viral hepatitis C
B18.2 [45590846]
—
1.0e+50
—
—
—
—
3.5e+00
—
—
cases:1.00%
controls:0.00%
—
—
—
—
—
—
—
—
cases:3.27%
controls:0.10%
—
5
0
493
4972
—
—
—
—
16
5
474
4909
Undifferentiated schizophrenia continuous
F20.30 [2000501944]
—
—
—
—
—
—
3.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.88%
controls:0.12%
—
—
—
—
—
—
19
6
471
4908
oxybutynin; oral, transdermal
G04BD04 [21602637]
1.7e+00
—
—
—
—
—
1.8e+00
cases:1.81%
controls:0.34%
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.24%
9
17
489
4955
—
—
—
—
—
7
12
483
4902
clomipramine; oral, parenteral
N06AA04 [21604691]
3.4e+00
—
—
—
—
—
—
cases:3.61%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
—
—
18
6
480
4966
—
—
—
—
—
—
Headache
R51.80 [2000503603]
1.4e+00
2.1e+00
—
—
—
2.0e+00
1.5e+00
cases:1.81%
controls:0.44%
cases:1.00%
controls:0.12%
—
—
—
—
—
—
cases:1.82%
controls:0.26%
cases:4.49%
controls:1.08%
9
22
489
4950
5
6
493
4966
—
—
—
9
13
486
4944
22
53
468
4861
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
—
—
—
—
—
2.1e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:1.82%
controls:0.22%
cases:5.71%
controls:1.67%
—
—
—
—
—
9
11
486
4946
28
82
462
4832
pH of Serum or Plasma
2753-2 [3018418]
—
—
—
—
—
2.2e+00
1.2e+00
—
—
—
—
—
—
—
—
—
—
cases:1.21%
controls:0.14%
cases:3.47%
controls:1.04%
—
—
—
—
—
6
7
489
4950
17
51
473
4863
orphenadrine, combinations
M03BC51 [21604113]
1.1e+00
1.3e+00
2.1e+00
—
—
3.3e-01
9.8e-01
cases:5.22%
controls:1.77%
cases:2.41%
controls:0.68%
cases:1.00%
controls:0.12%
—
—
—
—
cases:1.01%
controls:0.73%
cases:4.90%
controls:1.89%
26
88
472
4884
12
34
486
4938
5
6
493
4966
—
—
5
36
490
4921
24
93
466
4821
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
-1.0e+50
—
—
1.0e+50
1.0e+50
1.9e+00
1.5e+00
cases:0.00%
controls:0.18%
—
—
—
—
cases:1.00%
controls:0.00%
cases:1.41%
controls:0.00%
cases:2.63%
controls:0.40%
cases:6.53%
controls:1.61%
0
9
498
4963
—
—
5
0
493
4972
7
0
491
4972
13
20
482
4937
32
79
458
4835
loperamide; oral
A07DA03 [21600646]
1.6e+00
—
—
—
—
—
1.7e+00
cases:1.81%
controls:0.36%
—
—
—
—
—
—
—
—
—
—
cases:2.86%
controls:0.53%
9
18
489
4954
—
—
—
—
—
14
26
476
4888
loperamide oxide; oral
A07DA05 [21600648]
1.6e+00
—
—
—
—
—
1.7e+00
cases:1.81%
controls:0.36%
—
—
—
—
—
—
—
—
—
—
cases:2.86%
controls:0.53%
9
18
489
4954
—
—
—
—
—
14
26
476
4888
Medical abortion, complete or unspecified, without complication
O04.9 [45543909]
1.5e+00
1.1e+00
—
—
—
1.8e+00
7.3e-01
cases:2.61%
controls:0.60%
cases:1.41%
controls:0.46%
—
—
—
—
—
—
cases:1.62%
controls:0.26%
cases:2.65%
controls:1.30%
13
30
485
4942
7
23
491
4949
—
—
—
8
13
487
4944
13
64
477
4850
Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]
—
1.7e+00
—
—
—
2.0e+00
1.3e+00
—
—
cases:1.20%
controls:0.22%
—
—
—
—
—
—
cases:1.21%
controls:0.16%
cases:4.49%
controls:1.28%
—
6
11
492
4961
—
—
—
6
8
489
4949
22
63
468
4851
tizanidine; oral
M03BX02 [21604116]
4.7e-01
7.0e-01
2.1e+00
—
—
3.1e-01
4.4e-01
cases:12.45%
controls:8.17%
cases:6.02%
controls:3.08%
cases:2.01%
controls:0.24%
—
—
—
—
cases:5.45%
controls:4.05%
cases:18.98%
controls:13.13%
62
406
436
4566
30
153
468
4819
10
12
488
4960
—
—
27
201
468
4756
93
645
397
4269
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
6.9e-01
1.2e+00
—
—
—
1.3e+00
7.6e-01
cases:5.82%
controls:3.02%
cases:3.21%
controls:1.01%
—
—
—
—
—
—
cases:2.83%
controls:0.79%
cases:7.96%
controls:3.89%
29
150
469
4822
16
50
482
4922
—
—
—
14
39
481
4918
39
191
451
4723
methylprednisolone; oral, parenteral
H02AB04 [21602732]
9.1e-01
2.8e-01
—
—
—
1.3e+00
1.0e+00
cases:3.82%
controls:1.57%
cases:1.00%
controls:0.76%
—
—
—
—
—
—
cases:2.42%
controls:0.69%
cases:4.69%
controls:1.71%
19
78
479
4894
5
38
493
4934
—
—
—
12
34
483
4923
23
84
467
4830
CBC panel - Blood by Automated count
58410-2 [40761511]
—
7.1e-01
9.2e-01
—
2.1e+00
1.0e+00
4.0e-01
—
—
cases:3.41%
controls:1.71%
cases:1.20%
controls:0.48%
—
—
cases:2.81%
controls:0.34%
cases:5.86%
controls:2.22%
cases:10.41%
controls:7.24%
—
17
85
481
4887
6
24
492
4948
—
14
17
484
4955
29
110
466
4847
51
356
439
4558
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
—
8.0e-01
8.2e-01
—
2.2e+00
9.7e-01
4.1e-01
—
—
cases:4.02%
controls:1.85%
cases:1.00%
controls:0.44%
—
—
cases:3.21%
controls:0.38%
cases:5.86%
controls:2.30%
cases:10.20%
controls:7.02%
—
20
92
478
4880
5
22
493
4950
—
16
19
482
4953
29
114
466
4843
50
345
440
4569
pantoprazole; oral, parenteral
A02BC02 [21600097]
6.2e-01
1.0e+00
1.3e+00
—
—
1.1e+00
1.0e+00
cases:4.22%
controls:2.31%
cases:3.82%
controls:1.43%
cases:1.00%
controls:0.28%
—
—
—
—
cases:4.65%
controls:1.65%
cases:13.06%
controls:5.09%
21
115
477
4857
19
71
479
4901
5
14
493
4958
—
—
23
82
472
4875
64
250
426
4664
orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]
9.9e-01
1.3e+00
1.8e+00
—
—
8.4e-01
7.8e-01
cases:6.43%
controls:2.49%
cases:3.41%
controls:0.93%
cases:1.00%
controls:0.16%
—
—
—
—
cases:2.22%
controls:0.97%
cases:7.35%
controls:3.52%
32
124
466
4848
17
46
481
4926
5
8
493
4964
—
—
11
48
484
4909
36
173
454
4741
orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]
9.9e-01
1.3e+00
1.8e+00
—
—
8.4e-01
7.8e-01
cases:6.43%
controls:2.49%
cases:3.41%
controls:0.93%
cases:1.00%
controls:0.16%
—
—
—
—
cases:2.22%
controls:0.97%
cases:7.35%
controls:3.52%
32
124
466
4848
17
46
481
4926
5
8
493
4964
—
—
11
48
484
4909
36
173
454
4741
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
—
—
—
—
—
2.0e+00
1.1e+00
—
—
—
—
—
—
—
—
—
—
cases:2.02%
controls:0.28%
cases:5.71%
controls:1.97%
—
—
—
—
—
10
14
485
4943
28
97
462
4817
Low back pain
M54.5 [45553207]
1.2e+00
1.9e+00
—
—
—
1.4e+00
1.1e+00
cases:2.01%
controls:0.64%
cases:2.01%
controls:0.30%
—
—
—
—
—
—
cases:1.62%
controls:0.40%
cases:4.08%
controls:1.36%
10
32
488
4940
10
15
488
4957
—
—
—
8
20
487
4937
20
67
470
4847
sulpiride; oral, parenteral
N05AL01 [21604548]
3.0e+00
—
—
—
—
—
—
cases:2.01%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
—
—
10
5
488
4967
—
—
—
—
—
—
Methadone [Presence] in Urine by Screen method
19550-3 [3028707]
—
—
—
—
—
—
3.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.06%
controls:0.16%
—
—
—
—
—
—
15
8
475
4906
Bipolar affective disorder
F31 [45595902]
—
—
—
—
—
—
3.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.06%
controls:0.16%
—
—
—
—
—
—
15
8
475
4906
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
5.6e-01
9.0e-01
1.1e+00
—
1.3e+00
8.7e-01
6.2e-01
cases:18.47%
controls:11.46%
cases:7.23%
controls:3.06%
cases:1.41%
controls:0.46%
—
—
cases:1.41%
controls:0.38%
cases:5.25%
controls:2.28%
cases:8.98%
controls:5.05%
92
570
406
4402
36
152
462
4820
7
23
491
4949
—
7
19
491
4953
26
113
469
4844
44
248
446
4666
Retention of urine
R33 [45587507]
—
—
—
—
—
—
2.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.24%
controls:0.12%
—
—
—
—
—
—
11
6
479
4908
Alcohol intoxication UNS
F10.09 [2000501676]
—
—
—
—
—
—
2.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.10%
—
—
—
—
—
—
9
5
481
4909
escitalopram; oral
N06AB10 [21604718]
1.8e+00
1.3e+00
—
—
—
1.1e+00
1.1e+00
cases:3.01%
controls:0.52%
cases:1.41%
controls:0.40%
—
—
—
—
—
—
cases:1.62%
controls:0.52%
cases:4.29%
controls:1.42%
15
26
483
4946
7
20
491
4952
—
—
—
8
26
487
4931
21
70
469
4844
Asthma, unspecified
J45.9 [45562456]
—
1.3e+00
—
—
—
1.8e+00
1.1e+00
—
—
cases:1.20%
controls:0.32%
—
—
—
—
—
—
cases:2.02%
controls:0.34%
cases:3.27%
controls:1.10%
—
6
16
492
4956
—
—
—
10
17
485
4940
16
54
474
4860
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
8.4e-01
1.3e+00
—
—
—
1.5e+00
1.4e+00
cases:1.81%
controls:0.78%
cases:1.20%
controls:0.34%
—
—
—
—
—
—
cases:1.82%
controls:0.42%
cases:6.12%
controls:1.55%
9
39
489
4933
6
17
492
4955
—
—
—
9
21
486
4936
30
76
460
4838
Pain localized to other parts of lower abdomen
R10.3 [45534426]
1.1e+00
1.4e+00
—
—
—
1.5e+00
1.3e+00
cases:2.21%
controls:0.72%
cases:1.20%
controls:0.30%
—
—
—
—
—
—
cases:2.02%
controls:0.44%
cases:5.92%
controls:1.71%
11
36
487
4936
6
15
492
4957
—
—
—
10
22
485
4935
29
84
461
4830
nizatidine; oral, parenteral
A02BA04 [21600085]
1.2e+00
1.6e+00
—
—
—
1.7e+00
1.6e+00
cases:4.42%
controls:1.37%
cases:1.61%
controls:0.34%
—
—
—
—
—
—
cases:1.41%
controls:0.26%
cases:3.27%
controls:0.67%
22
68
476
4904
8
17
490
4955
—
—
—
7
13
488
4944
16
33
474
4881
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
F19.1 [45552459]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.63%
controls:0.10%
—
—
—
—
—
—
8
5
482
4909
Clinic/Center
261Q00000X [38004207]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.63%
controls:0.10%
—
—
—
—
—
—
8
5
482
4909
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
—
6.3e-01
8.7e-01
—
2.0e+00
8.2e-01
1.6e-01
—
—
cases:3.01%
controls:1.63%
cases:1.00%
controls:0.42%
—
—
cases:2.41%
controls:0.34%
cases:5.05%
controls:2.30%
cases:7.76%
controls:6.70%
—
15
81
483
4891
5
21
493
4951
—
12
17
486
4955
25
114
470
4843
38
329
452
4585
Procedure duration 90 to 119 minutes
ZXE13 [2001311404]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.04%
controls:0.14%
—
—
—
—
—
—
10
7
480
4907
Moderate depressive episode
F32.1 [45552478]
2.7e+00
—
—
—
1.0e+50
—
1.9e+00
cases:2.81%
controls:0.20%
—
—
—
—
—
—
cases:1.00%
controls:0.00%
—
—
cases:1.22%
controls:0.18%
14
10
484
4962
—
—
—
5
0
493
4972
—
6
9
484
4905
triamcinolone and antiseptics
D07BB03 [21602150]
1.1e+00
1.6e+00
—
—
—
1.1e+00
2.9e-01
cases:4.62%
controls:1.61%
cases:2.01%
controls:0.42%
—
—
—
—
—
—
cases:1.21%
controls:0.40%
cases:2.24%
controls:1.69%
23
80
475
4892
10
21
488
4951
—
—
—
6
20
489
4937
11
83
479
4831
vortioxetine; oral
N06AX26 [44819158]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.10%
—
—
—
—
—
—
7
5
483
4909
Acute pancreatitis
K85 [45567331]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.10%
—
—
—
—
—
—
7
5
483
4909
Melaena
K92.1 [45533624]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.63%
controls:0.12%
—
—
—
—
—
—
8
6
482
4908
Dysthymia
F34.1 [45586238]
1.8e+00
—
—
—
—
2.6e+00
—
cases:1.00%
controls:0.16%
—
—
—
—
—
—
—
—
cases:1.62%
controls:0.12%
—
—
5
8
493
4964
—
—
—
—
8
6
487
4951
—
Urgent procedure
ZXD05 [2001311386]
7.9e-01
1.4e+00
—
—
—
1.8e+00
8.0e-01
cases:2.01%
controls:0.93%
cases:2.01%
controls:0.52%
—
—
—
—
—
—
cases:2.83%
controls:0.48%
cases:8.16%
controls:3.83%
10
46
488
4926
10
26
488
4946
—
—
—
14
24
481
4933
40
188
450
4726
Social worker
Z2446 [2001311559]
1.9e+00
—
—
—
—
—
2.6e+00
cases:1.20%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.14%
6
9
492
4963
—
—
—
—
—
9
7
481
4907
Remote contact by phone
ZYC01 [2001311579]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.14%
—
—
—
—
—
—
9
7
481
4907
Platelets [#/volume] in Blood
26515-7 [3007461]
-7.9e-02
6.6e-01
9.6e-01
—
1.8e+00
7.5e-01
2.3e-01
cases:1.00%
controls:1.09%
cases:4.22%
controls:2.23%
cases:1.61%
controls:0.62%
—
—
cases:3.21%
controls:0.54%
cases:6.26%
controls:3.05%
cases:10.41%
controls:8.47%
5
54
493
4918
21
111
477
4861
8
31
490
4941
—
16
27
482
4945
31
151
464
4806
51
416
439
4498
MCH [Entitic mass]
28539-5 [3035941]
-7.9e-02
6.6e-01
9.6e-01
—
1.8e+00
7.5e-01
2.2e-01
cases:1.00%
controls:1.09%
cases:4.22%
controls:2.23%
cases:1.61%
controls:0.62%
—
—
cases:3.21%
controls:0.54%
cases:6.26%
controls:3.07%
cases:10.41%
controls:8.55%
5
54
493
4918
21
111
477
4861
8
31
490
4941
—
16
27
482
4945
31
152
464
4805
51
420
439
4494
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
-7.9e-02
6.6e-01
9.6e-01
—
1.8e+00
7.5e-01
2.2e-01
cases:1.00%
controls:1.09%
cases:4.22%
controls:2.23%
cases:1.61%
controls:0.62%
—
—
cases:3.21%
controls:0.54%
cases:6.26%
controls:3.07%
cases:10.41%
controls:8.55%
5
54
493
4918
21
111
477
4861
8
31
490
4941
—
16
27
482
4945
31
152
464
4805
51
420
439
4494
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
-7.9e-02
6.6e-01
9.6e-01
—
1.8e+00
7.5e-01
2.2e-01
cases:1.00%
controls:1.09%
cases:4.22%
controls:2.23%
cases:1.61%
controls:0.62%
—
—
cases:3.21%
controls:0.54%
cases:6.26%
controls:3.07%
cases:10.41%
controls:8.55%
5
54
493
4918
21
111
477
4861
8
31
490
4941
—
16
27
482
4945
31
152
464
4805
51
420
439
4494
cetirizine; oral
R06AE07 [21603497]
3.1e-01
7.8e-01
—
—
—
1.0e+00
7.6e-01
cases:11.45%
controls:8.67%
cases:7.03%
controls:3.34%
—
—
—
—
—
—
cases:8.08%
controls:3.13%
cases:15.10%
controls:7.67%
57
431
441
4541
35
166
463
4806
—
—
—
40
155
455
4802
74
377
416
4537
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
-7.9e-02
6.6e-01
9.6e-01
—
1.8e+00
7.4e-01
2.2e-01
cases:1.00%
controls:1.09%
cases:4.22%
controls:2.23%
cases:1.61%
controls:0.62%
—
—
cases:3.21%
controls:0.54%
cases:6.26%
controls:3.09%
cases:10.41%
controls:8.55%
5
54
493
4918
21
111
477
4861
8
31
490
4941
—
16
27
482
4945
31
153
464
4804
51
420
439
4494
Leukocytes [#/volume] in Blood
26464-8 [3010813]
-1.2e-01
6.7e-01
9.2e-01
—
1.8e+00
7.7e-01
2.2e-01
cases:1.00%
controls:1.13%
cases:4.22%
controls:2.21%
cases:1.61%
controls:0.64%
—
—
cases:3.21%
controls:0.56%
cases:6.46%
controls:3.09%
cases:10.41%
controls:8.55%
5
56
493
4916
21
110
477
4862
8
32
490
4940
—
16
28
482
4944
32
153
463
4804
51
420
439
4494
Catheterisation of bladder
TKC20 [2001306020]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.45%
controls:0.20%
—
—
—
—
—
—
12
10
478
4904
Procedure duration 50 to 59 minutes
ZXE06 [2001311400]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.45%
controls:0.20%
—
—
—
—
—
—
12
10
478
4904
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.29%
controls:0.37%
—
—
—
—
—
—
21
18
469
4896
Unspecified mood [affective] disorder
F39 [45591137]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.10%
—
—
—
—
—
—
6
5
484
4909
Acute pancreatitis caused by alcohol
K86.00 [2000502944]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.10%
—
—
—
—
—
—
6
5
484
4909
Pneumonitis due to food and vomit
J69.0 [45591562]
—
—
—
1.0e+50
—
—
2.5e+00
—
—
—
—
—
—
cases:1.81%
controls:0.00%
—
—
—
—
cases:1.22%
controls:0.10%
—
—
—
9
0
489
4972
—
—
6
5
484
4909
More than one and less than three hours
ZXE10 [2001311401]
2.2e-01
1.0e+00
—
—
—
1.7e+00
7.7e-01
cases:1.20%
controls:0.97%
cases:1.00%
controls:0.36%
—
—
—
—
—
—
cases:2.22%
controls:0.40%
cases:6.53%
controls:3.13%
6
48
492
4924
5
18
493
4954
—
—
—
11
20
484
4937
32
154
458
4760
Haematemesis
K92.0 [45605964]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.12%
—
—
—
—
—
—
7
6
483
4908
Extensive abdominal CT
JN3BD [2001305556]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.12%
—
—
—
—
—
—
7
6
483
4908
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
-1.3e-01
6.5e-01
9.6e-01
—
1.7e+00
7.3e-01
2.1e-01
cases:1.00%
controls:1.15%
cases:4.22%
controls:2.25%
cases:1.61%
controls:0.62%
—
—
cases:3.21%
controls:0.58%
cases:6.26%
controls:3.11%
cases:10.41%
controls:8.59%
5
57
493
4915
21
112
477
4860
8
31
490
4941
—
16
29
482
4943
31
154
464
4803
51
422
439
4492
Home Visit
OMOP4822459 [581476]
5.7e-01
1.4e+00
—
—
—
1.4e+00
1.1e+00
cases:1.20%
controls:0.68%
cases:1.20%
controls:0.30%
—
—
—
—
—
—
cases:2.02%
controls:0.50%
cases:4.29%
controls:1.53%
6
34
492
4938
6
15
492
4957
—
—
—
10
25
485
4932
21
75
469
4839
Monitored bed care
WX892 [2001310850]
—
—
—
1.0e+50
—
—
2.5e+00
—
—
—
—
—
—
cases:1.61%
controls:0.00%
—
—
—
—
cases:1.63%
controls:0.14%
—
—
—
8
0
490
4972
—
—
8
7
482
4907
lamotrigine; oral
N03AX09 [21604431]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.69%
controls:0.43%
—
—
—
—
—
—
23
21
467
4893
Bloodpressure measurement
XF600 [2001303376]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.16%
—
—
—
—
—
—
9
8
481
4906
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
—
7.5e-01
1.1e+00
—
2.3e+00
8.0e-01
5.2e-01
—
—
cases:2.81%
controls:1.35%
cases:1.20%
controls:0.40%
—
—
cases:3.41%
controls:0.34%
cases:4.44%
controls:2.04%
cases:9.80%
controls:6.08%
—
14
67
484
4905
6
20
492
4952
—
17
17
481
4955
22
101
473
4856
48
299
442
4615
Drugs identified in Urine by Screen method Nominal
12286-1 [3011288]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.45%
controls:0.24%
—
—
—
—
—
—
12
12
478
4902
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.45%
controls:0.24%
—
—
—
—
—
—
12
12
478
4902
Depressive disorder
P76 [2002000870]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.04%
controls:0.20%
—
—
—
—
—
—
10
10
480
4904
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.04%
controls:0.20%
—
—
—
—
—
—
10
10
480
4904
Epilepsy
G40 [45595935]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.63%
controls:0.16%
—
—
—
—
—
—
8
8
482
4906
lidocaine
C05AD01 [21601618]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.12%
—
—
—
—
—
—
6
6
484
4908
Recurrent depressive disorder, currently in remission
F33.4 [45533100]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.12%
—
—
—
—
—
—
6
6
484
4908
Dedicated profession-specific psychiatric intervention, individual
IEY05 [2001304224]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.12%
—
—
—
—
—
—
6
6
484
4908
lidocaine; ointment
D04AB01 [21602020]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.12%
—
—
—
—
—
—
6
6
484
4908
Acute abdomen
R10.0 [45563289]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.12%
—
—
—
—
—
—
6
6
484
4908
Headache
R51 [45558474]
1.3e+00
—
—
—
—
—
2.2e+00
cases:1.00%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.20%
5
14
493
4958
—
—
—
—
—
9
10
481
4904
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.16%
—
—
—
—
—
—
7
8
483
4906
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.16%
—
—
—
—
—
—
7
8
483
4906
Fracture of upper end of humerus
S42.2 [45544677]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.16%
—
—
—
—
—
—
7
8
483
4906
pH of Capillary blood
2745-8 [3009343]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.16%
—
—
—
—
—
—
7
8
483
4906
Car occupant [any] injured in unspecified traffic accident
V49.9 [45566025]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.16%
—
—
—
—
—
—
7
8
483
4906
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.16%
—
—
—
—
—
—
7
8
483
4906
Loss of teeth due to accident, extraction or local periodontal disease
K08.1 [45591573]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.14%
—
—
—
—
—
—
6
7
484
4907
Social phobias
F40.1 [45595907]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.14%
—
—
—
—
—
—
6
7
484
4907
Mild depressive episode without somatic syndrome
F32.00 [2000501978]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.06%
controls:0.37%
—
—
—
—
—
—
15
18
475
4896
Unknown and unspecified causes of morbidity
R69 [45558480]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.63%
controls:0.20%
—
—
—
—
—
—
8
10
482
4904
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
2.1e+00
—
—
—
—
—
1.2e+00
cases:1.61%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:1.63%
controls:0.49%
8
10
490
4962
—
—
—
—
—
8
24
482
4890
codeine and paracetamol
N02AJ06 [1123647]
4.3e-01
1.1e+00
—
—
—
1.1e+00
9.2e-01
cases:2.81%
controls:1.85%
cases:1.81%
controls:0.58%
—
—
—
—
—
—
cases:2.63%
controls:0.85%
cases:4.29%
controls:1.75%
14
92
484
4880
9
29
489
4943
—
—
—
13
42
482
4915
21
86
469
4828
macrogol; oral
A06AD15 [21600575]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.18%
—
—
—
—
—
—
7
9
483
4905
Problems related to unwanted pregnancy
Z64.0 [45581053]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.16%
—
—
—
—
—
—
6
8
484
4906
Abdominal pain/cramps general
D01 [2002000300]
-1.0e+50
—
—
—
—
—
2.0e+00
cases:0.00%
controls:0.24%
—
—
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.16%
0
12
498
4960
—
—
—
—
—
6
8
484
4906
Pain localized to upper abdomen
R10.1 [45568111]
9.7e-01
2.0e+00
—
—
—
—
9.6e-01
cases:1.00%
controls:0.38%
cases:1.20%
controls:0.16%
—
—
—
—
—
—
—
—
cases:2.04%
controls:0.79%
5
19
493
4953
6
8
492
4964
—
—
—
—
10
39
480
4875
potassium chloride; oral
A12BA01 [21600877]
2.0e+00
1.7e+00
—
—
—
—
1.2e+00
cases:1.20%
controls:0.16%
cases:1.20%
controls:0.22%
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.39%
6
8
492
4964
6
11
492
4961
—
—
—
—
6
19
484
4895
Fungus identified in Specimen by Culture
580-1 [3000494]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.24%
controls:0.31%
—
—
—
—
—
—
11
15
479
4899
Telehealth
OMOP5556618 [722455]
5.3e-01
5.1e-01
1.4e+00
—
8.8e-01
7.2e-01
6.0e-01
cases:6.43%
controls:3.90%
cases:3.82%
controls:2.33%
cases:2.01%
controls:0.50%
—
—
cases:1.20%
controls:0.50%
cases:5.25%
controls:2.62%
cases:9.80%
controls:5.62%
32
194
466
4778
19
116
479
4856
10
25
488
4947
—
6
25
492
4947
26
130
469
4827
48
276
442
4638
Malaise and fatigue
R53 [45553741]
—
—
—
—
—
-1.0e+50
2.0e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
cases:3.88%
controls:0.55%
—
—
—
—
—
0
7
495
4950
19
27
471
4887
Insertion of intrauterine device
TLC00 [2001306647]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.04%
controls:0.28%
—
—
—
—
—
—
10
14
480
4900
Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21416-3 [3003510]
-1.0e+50
—
—
—
—
2.0e+00
8.9e-01
cases:0.00%
controls:0.12%
—
—
—
—
—
—
—
—
cases:2.02%
controls:0.28%
cases:3.06%
controls:1.28%
0
6
498
4966
—
—
—
—
10
14
485
4943
15
63
475
4851
Buprenorphine [Presence] in Urine by Screen method
93494-3 [1001926]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.86%
controls:0.41%
—
—
—
—
—
—
14
20
476
4894
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
—
—
—
—
2.3e+00
1.1e+00
8.4e-01
—
—
—
—
—
—
—
—
cases:1.00%
controls:0.10%
cases:2.63%
controls:0.87%
cases:7.55%
controls:3.42%
—
—
—
—
5
5
493
4967
13
43
482
4914
37
168
453
4746
Gas panel - Venous blood
24339-4 [3000991]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.20%
—
—
—
—
—
—
7
10
483
4904
Moderate depressive episode with somatic syndrome
F32.11 [2000501981]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.20%
—
—
—
—
—
—
7
10
483
4904
Mental disorder, not otherwise specified
F99 [45605525]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.20%
—
—
—
—
—
—
7
10
483
4904
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.26%
—
—
—
—
—
—
9
13
481
4901
Generalized anxiety disorder
F41.1 [45571764]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.24%
controls:0.33%
—
—
—
—
—
—
11
16
479
4898
Cocaine [Presence] in Urine
3397-7 [3016879]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.06%
controls:0.47%
—
—
—
—
—
—
15
23
475
4891
Psychological sympt/compl other
P29 [2002000823]
1.7e+00
—
—
—
—
—
1.9e+00
cases:1.00%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.28%
5
9
493
4963
—
—
—
—
—
9
14
481
4900
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.28%
—
—
—
—
—
—
9
14
481
4900
metronidazole; oral, rectal
P01AB01 [21604857]
7.0e-01
1.2e+00
—
—
—
6.3e-01
5.5e-01
cases:13.65%
controls:7.26%
cases:4.42%
controls:1.41%
—
—
—
—
—
—
cases:2.02%
controls:1.09%
cases:5.31%
controls:3.13%
68
361
430
4611
22
70
476
4902
—
—
—
10
54
485
4903
26
154
464
4760
bupropion; oral
N06AX12 [21604741]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.22%
—
—
—
—
—
—
7
11
483
4903
Dyspnoea
R06.0 [45558449]
1.3e+00
1.9e+00
—
—
—
1.2e+00
5.4e-01
cases:1.61%
controls:0.44%
cases:1.41%
controls:0.22%
—
—
—
—
—
—
cases:1.21%
controls:0.38%
cases:2.65%
controls:1.57%
8
22
490
4950
7
11
491
4961
—
—
—
6
19
489
4938
13
77
477
4837
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
—
4.8e-01
—
—
—
1.1e+00
7.3e-01
—
—
cases:1.00%
controls:0.62%
—
—
—
—
—
—
cases:2.63%
controls:0.87%
cases:6.94%
controls:3.46%
—
5
31
493
4941
—
—
—
13
43
482
4914
34
170
456
4744
gabapentin; oral
N02BF01 [955005]
1.7e+00
—
—
—
—
—
1.8e+00
cases:1.00%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:5.31%
controls:0.88%
5
9
493
4963
—
—
—
—
—
26
43
464
4871
Scheduled procedure
ZXD10 [2001311387]
6.3e-01
8.2e-01
—
—
-1.0e+50
1.1e+00
7.6e-01
cases:2.21%
controls:1.19%
cases:1.81%
controls:0.80%
—
—
—
—
cases:0.00%
controls:0.12%
cases:3.43%
controls:1.19%
cases:11.22%
controls:5.60%
11
59
487
4913
9
40
489
4932
—
—
0
6
498
4966
17
59
478
4898
55
275
435
4639
aciclovir
D06BB03 [21602085]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.63%
controls:0.26%
—
—
—
—
—
—
8
13
482
4901
Contusion of thorax
S20.2 [45597402]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.63%
controls:0.26%
—
—
—
—
—
—
8
13
482
4901
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
-1.0e+50
8.2e-01
—
—
2.1e+00
1.2e+00
6.4e-01
cases:0.00%
controls:0.26%
cases:1.00%
controls:0.44%
—
—
—
—
cases:1.00%
controls:0.12%
cases:2.83%
controls:0.89%
cases:8.16%
controls:4.46%
0
13
498
4959
5
22
493
4950
—
—
5
6
493
4966
14
44
481
4913
40
219
450
4695
Choriogonadotropin [Units/volume] in Urine
25372-4 [3023511]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.31%
—
—
—
—
—
—
9
15
481
4899
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.04%
controls:0.35%
—
—
—
—
—
—
10
17
480
4897
melatonin; oral
N05CH01 [21604659]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.04%
controls:0.35%
—
—
—
—
—
—
10
17
480
4897
Base excess in Venous blood by calculation
1927-3 [3002032]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.04%
controls:0.35%
—
—
—
—
—
—
10
17
480
4897
Amphetamines [Presence] in Urine
3349-8 [3027944]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.86%
controls:0.49%
—
—
—
—
—
—
14
24
476
4890
Opiates [Presence] in Urine
3879-4 [3027008]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.06%
controls:0.53%
—
—
—
—
—
—
15
26
475
4888
Benzodiazepines [Presence] in Urine
3390-2 [3000764]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.06%
controls:0.53%
—
—
—
—
—
—
15
26
475
4888
Cannabinoids [Presence] in Urine
3427-2 [3028300]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.06%
controls:0.53%
—
—
—
—
—
—
15
26
475
4888
Abdominal ultrasound examination
JN3AE [2001305555]
1.3e+00
—
—
—
—
—
1.8e+00
cases:1.00%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.24%
5
14
493
4958
—
—
—
—
—
7
12
483
4902
Excessive ear wax
H81 [2002000536]
-1.0e+50
—
—
—
—
—
1.8e+00
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.24%
0
7
498
4965
—
—
—
—
—
7
12
483
4902
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.24%
—
—
—
—
—
—
7
12
483
4902
Counselling and guidance which enhance independent living
R2130 [2001310196]
—
—
—
—
—
-1.0e+50
1.8e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
cases:1.43%
controls:0.24%
—
—
—
—
—
0
5
495
4952
7
12
483
4902
Therapeutic discussion
SPAT1240 [2001700341]
—
1.9e+00
—
—
—
1.8e+00
1.2e+00
—
—
cases:1.20%
controls:0.18%
—
—
—
—
—
—
cases:1.41%
controls:0.24%
cases:1.63%
controls:0.51%
—
6
9
492
4963
—
—
—
7
12
488
4945
8
25
482
4889
paracetamol, combinations excl. psycholeptics
N02BE51 [21604348]
8.6e-01
9.9e-01
1.6e+00
—
—
3.6e-01
8.9e-01
cases:6.63%
controls:2.92%
cases:2.81%
controls:1.07%
cases:1.00%
controls:0.20%
—
—
—
—
cases:1.21%
controls:0.85%
cases:5.10%
controls:2.16%
33
145
465
4827
14
53
484
4919
5
10
493
4962
—
—
6
42
489
4915
25
106
465
4808
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
1.6e+00
—
—
—
—
—
1.7e+00
cases:1.41%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
cases:3.06%
controls:0.55%
7
14
491
4958
—
—
—
—
—
15
27
475
4887
pH of Venous blood
2746-6 [3012544]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.04%
controls:0.37%
—
—
—
—
—
—
10
18
480
4896
pregabalin; oral
N02BF02 [955152]
1.2e+00
1.8e+00
—
—
—
1.6e+00
1.7e+00
cases:1.20%
controls:0.38%
cases:1.20%
controls:0.20%
—
—
—
—
—
—
cases:1.21%
controls:0.24%
cases:3.06%
controls:0.57%
6
19
492
4953
6
10
492
4962
—
—
—
6
12
489
4945
15
28
475
4886
tolfenamic acid; oral, rectal
M01AG02 [21603988]
6.5e-01
1.1e+00
—
—
—
9.7e-01
7.4e-01
cases:7.23%
controls:3.92%
cases:3.21%
controls:1.15%
—
—
—
—
—
—
cases:2.63%
controls:1.01%
cases:4.69%
controls:2.30%
36
195
462
4777
16
57
482
4915
—
—
—
13
50
482
4907
23
113
467
4801
Irregular menstruation, unspecified
N92.6 [45539075]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.35%
—
—
—
—
—
—
9
17
481
4897
Sciatica
M54.3 [45586994]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.35%
—
—
—
—
—
—
9
17
481
4897
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
—
—
—
—
—
2.1e+00
1.7e+00
—
—
—
—
—
—
—
—
—
—
cases:1.01%
controls:0.12%
cases:1.84%
controls:0.35%
—
—
—
—
—
5
6
490
4951
9
17
481
4897
Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6357-8 [3024950]
—
—
-1.0e+50
—
—
1.7e+00
8.1e-01
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
cases:1.82%
controls:0.34%
cases:3.06%
controls:1.38%
—
—
0
5
498
4967
—
—
9
17
486
4940
15
68
475
4846
Hypothyroidism, unspecified
E03.9 [45537945]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.04%
controls:0.39%
—
—
—
—
—
—
10
19
480
4895
lidocaine, combinations
N01BB52 [21604241]
5.5e-01
-1.0e+50
—
—
—
2.0e+00
1.7e+00
cases:1.00%
controls:0.58%
cases:0.00%
controls:0.24%
—
—
—
—
—
—
cases:1.01%
controls:0.14%
cases:2.04%
controls:0.39%
5
29
493
4943
0
12
498
4960
—
—
—
5
7
490
4950
10
19
480
4895
Infectious Disease
44 [38004484]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.45%
controls:0.47%
—
—
—
—
—
—
12
23
478
4891
Syncope and collapse
R55 [45568141]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.86%
controls:0.55%
—
—
—
—
—
—
14
27
476
4887
clindamycin; oral, parenteral
J01FF01 [21602985]
8.5e-01
8.6e-01
—
—
—
1.1e+00
7.9e-01
cases:4.42%
controls:1.93%
cases:1.61%
controls:0.68%
—
—
—
—
—
—
cases:2.22%
controls:0.77%
cases:6.12%
controls:2.87%
22
96
476
4876
8
34
490
4938
—
—
—
11
38
484
4919
30
141
460
4773
methylprednisolone, combinations
H02BX01 [21602747]
5.5e-01
-1.0e+50
—
—
—
—
1.6e+00
cases:1.00%
controls:0.58%
cases:0.00%
controls:0.22%
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.37%
5
29
493
4943
0
11
498
4961
—
—
—
—
9
18
481
4896
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.63%
controls:0.33%
—
—
—
—
—
—
8
16
482
4898
Other symptoms involving abdomen and pelvis, Abdominal pain
7890A [2000407034]
1.6e+00
—
—
—
—
—
—
cases:1.81%
controls:0.36%
—
—
—
—
—
—
—
—
—
—
—
—
9
18
489
4954
—
—
—
—
—
—
Other chest pain
R07.3 [45597166]
—
2.0e+00
—
—
—
—
1.6e+00
—
—
cases:1.00%
controls:0.14%
—
—
—
—
—
—
—
—
cases:2.24%
controls:0.47%
—
5
7
493
4965
—
—
—
—
11
23
479
4891
salmeterol; inhalant
R03AC12 [21603266]
1.1e+00
1.2e+00
-1.0e+50
—
—
1.2e+00
1.6e+00
cases:1.41%
controls:0.46%
cases:1.00%
controls:0.30%
cases:0.00%
controls:0.14%
—
—
—
—
cases:1.21%
controls:0.36%
cases:2.04%
controls:0.43%
7
23
491
4949
5
15
493
4957
0
7
498
4965
—
—
6
18
489
4939
10
21
480
4893
Irrigation or wax removal of outer auditory canal
SPAT1033 [2001700134]
—
—
—
—
—
-1.0e+50
1.6e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.12%
cases:2.04%
controls:0.43%
—
—
—
—
—
0
6
495
4951
10
21
480
4893
Gastro-oesophageal reflux disease with oesophagitis
K21.0 [45543296]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.65%
controls:0.57%
—
—
—
—
—
—
13
28
477
4886
Dorsalgia, unspecified
M54.9 [45538791]
1.6e+00
—
—
—
—
—
1.6e+00
cases:1.41%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
cases:2.65%
controls:0.57%
7
14
491
4958
—
—
—
—
—
13
28
477
4886
Choriogonadotropin [Units/volume] in Serum or Plasma
19080-1 [3018171]
—
-1.0e+50
—
—
—
—
1.5e+00
—
—
cases:0.00%
controls:0.12%
—
—
—
—
—
—
—
—
cases:2.04%
controls:0.45%
—
0
6
498
4966
—
—
—
—
10
22
480
4892
oxycodone; oral, parenteral
N02AA05 [21604260]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.41%
—
—
—
—
—
—
9
20
481
4894
Cathetrisation of vein
TPH04 [2001309597]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.88%
controls:0.88%
—
—
—
—
—
—
19
43
471
4871
furosemide and potassium-sparing agents
C03EB01 [21601554]
1.5e+00
1.3e+00
—
—
—
—
1.4e+00
cases:1.81%
controls:0.40%
cases:1.00%
controls:0.28%
—
—
—
—
—
—
—
—
cases:1.43%
controls:0.37%
9
20
489
4952
5
14
493
4958
—
—
—
—
7
18
483
4896
Gastroenterology
10 [38004455]
9.9e-01
1.6e+00
—
—
—
1.1e+00
1.5e+00
cases:1.61%
controls:0.60%
cases:1.00%
controls:0.20%
—
—
—
—
—
—
cases:1.21%
controls:0.40%
cases:7.14%
controls:1.69%
8
30
490
4942
5
10
493
4962
—
—
—
6
20
489
4937
35
83
455
4831
Pneumonia, unspecified
J18.9 [45601123]
—
1.5e+00
—
—
—
1.5e+00
1.5e+00
—
—
cases:1.41%
controls:0.32%
—
—
—
—
—
—
cases:1.21%
controls:0.28%
cases:4.29%
controls:1.00%
—
7
16
491
4956
—
—
—
6
14
489
4943
21
49
469
4865
Exposure to unspecified factor
X59 [45756412]
1.3e+00
—
—
—
—
2.0e+00
1.5e+00
cases:1.81%
controls:0.48%
—
—
—
—
—
—
—
—
cases:1.01%
controls:0.14%
cases:2.65%
controls:0.61%
9
24
489
4948
—
—
—
—
5
7
490
4950
13
30
477
4884
Dizziness and giddiness
R42 [45568132]
1.5e+00
—
—
—
—
—
8.1e-01
cases:2.01%
controls:0.46%
—
—
—
—
—
—
—
—
—
—
cases:2.65%
controls:1.20%
10
23
488
4949
—
—
—
—
—
13
59
477
4855
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.43%
—
—
—
—
—
—
9
21
481
4893
Observation for suspected nervous system disorder
Z03.3 [45609903]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.43%
—
—
—
—
—
—
9
21
481
4893
Knee symptom/complaint
L15 [2002000639]
1.4e+00
—
—
—
—
—
1.5e+00
cases:1.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
cases:1.84%
controls:0.43%
5
13
493
4959
—
—
—
—
—
9
21
481
4893
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
-1.0e+50
—
—
—
1.0e+50
1.3e+00
1.5e+00
cases:0.00%
controls:0.14%
—
—
—
—
—
—
cases:1.00%
controls:0.00%
cases:1.21%
controls:0.34%
cases:5.10%
controls:1.22%
0
7
498
4965
—
—
—
5
0
493
4972
6
17
489
4940
25
60
465
4854
Nausea and vomiting
R11 [45539317]
—
—
—
—
—
—
1.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.04%
controls:0.49%
—
—
—
—
—
—
10
24
480
4890
Acute tubulo-interstitial nephritis
N10 [45543856]
—
—
—
—
—
—
1.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.45%
controls:0.59%
—
—
—
—
—
—
12
29
478
4885
dextropropoxyphene; oral
N02AC04 [21604278]
1.4e+00
—
—
—
—
—
—
cases:2.01%
controls:0.48%
—
—
—
—
—
—
—
—
—
—
—
—
10
24
488
4948
—
—
—
—
—
—
Low back symptom/complaint
L03 [2002000628]
8.4e-01
—
—
—
—
—
1.4e+00
cases:1.20%
controls:0.52%
—
—
—
—
—
—
—
—
—
—
cases:2.86%
controls:0.69%
6
26
492
4946
—
—
—
—
—
14
34
476
4880
isosorbide mononitrate; oral
C01DA14 [21600324]
1.4e+00
1.4e+00
—
—
—
1.1e+00
1.0e+00
cases:2.21%
controls:0.54%
cases:1.41%
controls:0.34%
—
—
—
—
—
—
cases:1.21%
controls:0.40%
cases:1.84%
controls:0.65%
11
27
487
4945
7
17
491
4955
—
—
—
6
20
489
4937
9
32
481
4882
Observation for other suspected diseases and conditions
Z03.89 [2000503757]
2.3e+00
—
—
—
—
—
1.4e+00
cases:1.00%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:2.24%
controls:0.57%
5
5
493
4967
—
—
—
—
—
11
28
479
4886
Otolaryngology
4 [38004449]
3.9e-01
7.7e-01
—
—
1.3e+00
6.5e-01
6.0e-01
cases:6.83%
controls:4.73%
cases:5.42%
controls:2.57%
—
—
—
—
cases:1.20%
controls:0.32%
cases:5.05%
controls:2.70%
cases:14.08%
controls:8.22%
34
235
464
4737
27
128
471
4844
—
—
6
16
492
4956
25
134
470
4823
69
404
421
4510
Thorax X-ray examination
GD1AA [2001303617]
7.0e-01
—
—
—
—
1.4e+00
1.4e+00
cases:1.61%
controls:0.80%
—
—
—
—
—
—
—
—
cases:1.41%
controls:0.34%
cases:3.06%
controls:0.79%
8
40
490
4932
—
—
—
—
7
17
488
4940
15
39
475
4875
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
—
—
—
—
—
1.1e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:1.01%
controls:0.34%
cases:3.88%
controls:1.04%
—
—
—
—
—
5
17
490
4940
19
51
471
4863

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
91
116
9.36
69.11
10.9
2.7
—
—
—
0
0
71
75
10.86
61.86
7.9
6.9
398.73
366.67
umol/l
0.90
63
70
39
20
21.06
50.71
3.2
6.7
127.65
143.27
umol/l
0.10
17
11
42
27
16.89
49.13
2.8
1.7
—
—
—
0
0
95
199
5.66
44.61
10.4
2.1
—
—
—
0
0
87
177
5.74
42.07
13.6
3.2
—
—
—
0
0
100
232
5.14
41.70
10.5
2.3
—
—
—
0
0
102
245
4.97
40.78
10.4
2.3
—
—
—
0
0
102
246
4.95
40.57
10.3
2.2
—
—
—
0
0
102
248
4.91
40.15
10.4
2.2
—
—
—
0
0
98
246
4.71
36.94
10.0
2.1
—
—
—
0
0
100
258
4.59
36.39
2.4
1.7
0.45
0.32
mg/l
0.88
56
122
254
1293
2.96
31.25
10.7
6.0
—
—
—
0
0
125
439
3.46
28.98
7.9
9.9
7.42
7.42
ph
0.40
77
241
124
435
3.46
28.79
7.6
9.9
1.83
0.78
mmol/l
1.67
107
366
216
1058
2.83
27.80
5.6
4.2
—
—
—
0
0
113
390
3.45
26.77
3.7
3.4
5.92
5.78
kpa
0.72
108
381
285
1650
2.69
25.81
5.0
3.6
33.72
31.87
u/l
0.28
268
1561
302
1805
2.69
25.54
8.1
6.7
1.20
1.21
mmol/l
4.09
291
1679
215
1103
2.66
24.61
4.3
2.6
—
—
—
0
0
228
1206
2.63
24.49
4.6
4.1
7.39
7.40
ph
0.92
170
873
106
374
3.33
24.06
3.8
3.5
1.39
2.03
mmol/l
0.80
92
328
108
387
3.28
23.89
3.7
3.4
7.37
7.39
ph
1.76
67
217
350
2297
2.74
23.75
7.6
6.8
9.57
10.78
umol/l
1.12
339
2188
294
1774
2.59
23.75
5.3
5.2
34.73
36.66
g/l
6.04
278
1688
134
552
2.95
23.24
7.9
8.0
103.33
103.94
mmol/l
0.53
134
552
136
570
2.90
22.81
1.9
1.7
1184.70
1190.06
nmol/l
0.02
105
442
243
1371
2.50
22.21
4.1
2.8
51.13
62.14
u/l
2.31
232
1281
32
45
7.53
21.87
2.8
1.7
1.87
1.03
promille
1.86
24
36
314
2015
2.50
21.33
8.3
7.5
1.20
1.21
mmol/l
2.63
289
1757
108
427
2.95
19.92
3.4
2.7
44.26
35.54
u/l
0.24
101
356
159
767
2.57
19.91
3.2
2.5
463.12
539.19
mosm/kgh2o
3.78
137
671
122
526
2.74
19.06
4.2
6.5
0.99
1.02
mmol/l
0.67
113
489
228
1319
2.34
18.88
4.1
3.0
28.63
52.82
e6/l
0.79
189
1002
91
338
3.07
18.67
7.9
10.5
—
—
—
0
0
174
900
2.43
18.54
3.2
2.6
8.55
6.62
e6/l
0.75
161
820
220
1288
2.26
17.33
3.4
2.1
367.85
231.78
u/l
0.72
211
1234
332
2304
2.31
17.16
10.1
6.7
0.60
0.56
e9/l
1.90
293
2017
332
2305
2.31
17.13
10.2
6.7
0.04
0.04
e9/l
0.13
292
2016
340
2394
2.31
16.81
12.2
7.0
0.16
0.19
e9/l
2.28
308
2120
251
1565
2.21
16.78
5.3
3.6
43.36
101.33
e6/l
1.15
192
1073
150
764
2.38
16.23
5.0
3.5
31.08
293.07
ng/l
3.45
106
529
334
2357
2.25
16.09
10.7
6.7
2.04
1.97
e9/l
0.45
300
2105
344
2473
2.25
15.60
8.1
5.0
6.50
6.57
mmol/l
0.26
334
2335
195
1126
2.20
15.50
4.0
2.9
0.54
0.40
e6/l
0.22
155
813
366
2715
2.29
15.12
7.2
4.1
4633.56
580.38
e6/l
—
9
40
421
3327
2.66
14.95
10.3
8.4
78.30
76.61
u/l
0.54
408
3177
180
1023
2.19
14.75
7.4
3.6
1.01
1.02
kg/l
4.49
128
685
292
2003
2.10
14.47
14.9
10.6
0.00
0.00
e9/l
0.21
245
1647
44
121
3.89
14.33
4.6
5.1
1.38
1.38
mmol/l
0.00
44
116
230
1452
2.08
14.19
7.5
3.5
7.12
8.17
mmol/l
2.56
208
1246
268
1796
2.06
13.97
14.3
9.7
1.17
1.14
inr
0.50
228
1488
139
726
2.27
13.90
3.0
2.5
2.46
2.44
mmol/l
1.37
120
656
107
502
2.44
13.67
2.2
1.6
—
—
—
0
0
349
2590
2.15
13.66
22.1
10.1
4.53
3.99
e9/l
4.10
325
2275
136
713
2.25
13.43
3.2
3.5
0.79
0.82
mmol/l
3.08
129
680
30
65
4.85
13.23
1.4
1.4
63.85
62.93
mmol/l
0.03
20
59
122
2079
0.45
12.94
4.0
3.0
—
—
—
0
0
223
1431
2.01
12.78
3.2
3.3
2.35
2.35
mmol/l
0.35
207
1308
117
606
2.21
11.74
2.2
2.0
—
—
—
0
0
106
532
2.26
11.46
2.3
2.7
10.69
7.06
umol/l
0.69
79
473
376
2960
2.08
11.36
5.8
4.2
—
3.45
—
0
9
224
1483
1.92
11.36
8.8
6.6
—
—
—
0
0
119
633
2.15
11.11
3.3
2.7
7.78
2.60
e6/l
1.85
64
292
180
1120
1.95
10.88
2.1
1.6
16.71
20.95
nmol/l
5.23
166
962
254
1794
1.84
10.17
2.6
2.0
87.44
98.64
pmol/l
4.34
153
912
174
1105
1.88
9.67
5.7
3.9
94.82
95.33
%
0.09
164
1082
38
125
3.21
9.45
1.6
1.3
—
—
—
0
0
260
1883
1.79
9.30
6.1
3.2
6.45
6.17
ph
3.14
138
1111
284
2123
1.78
9.00
10.3
6.9
8.52
8.61
%
0.23
272
2013
283
2114
1.78
8.99
10.2
6.8
0.65
0.72
%
1.26
270
1991
283
2119
1.77
8.87
10.1
6.7
2.31
2.86
%
4.80
271
2004
288
2172
1.77
8.76
10.5
6.8
27.52
28.65
%
1.06
276
2082
55
232
2.54
8.68
3.5
2.7
0.61
0.62
%
0.09
55
232
285
2155
1.75
8.47
9.8
6.6
58.02
56.88
%
1.00
279
2067
411
3486
2.00
8.15
6.2
4.4
14.28
14.53
pmol/l
1.31
394
3265
306
2378
1.74
8.09
5.4
3.5
0.00
0.02
estimate
0.79
58
447
300
2337
1.71
7.69
5.5
3.4
0.00
0.00
estimate
0.50
59
484
106
616
1.91
7.51
1.2
1.3
—
—
—
0
0
301
2361
1.69
7.38
5.5
3.4
0.00
0.00
estimate
-0.00
61
482
149
968
1.77
7.35
2.5
2.0
—
—
—
0
0
114
684
1.86
7.31
2.4
2.4
11.76
14.35
umol/l
3.26
102
639
108
645
1.86
7.00
2.3
2.4
2.36
2.39
g/l
0.19
95
601
14
17
8.44
6.86
3.1
3.2
28.80
35.78
umol/l
—
5
12
67
341
2.11
6.85
2.9
2.4
0.21
0.19
e6/l
0.07
60
323
13
14
9.50
6.82
1.9
1.9
19.01
15.94
umol/l
0.41
13
14
25
78
3.32
6.79
4.6
2.6
—
—
—
0
0
155
1043
1.70
6.65
2.7
2.1
2.85
2.90
mg/l
0.10
134
903
99
586
1.86
6.57
2.4
2.5
21.08
24.16
%
1.05
90
550
74
400
2.00
6.43
1.6
1.5
—
—
—
0
0
102
620
1.81
6.20
1.8
1.7
—
—
—
0
0
15
493
0.28
6.17
2.5
1.8
3.56
3.52
mmol/l
—
9
363
17
44
3.96
6.03
1.0
1.2
—
—
—
0
0
152
1043
1.66
5.96
2.0
1.8
0.82
1.06
mg/l
1.07
112
816
29
107
2.82
5.96
3.4
2.7
4.44
1.85
index
0.83
16
60
151
1041
1.64
5.79
2.3
3.2
1033.37
800.63
ng/l
0.23
123
853
73
409
1.92
5.71
2.0
2.5
0.20
0.23
g/l
2.32
66
385
385
3321
1.69
5.70
6.3
3.6
57.54
47.88
u/l
1.50
372
3172
29
111
2.71
5.58
1.2
1.2
2.00
12.62
e6/l
0.94
16
82
123
815
1.67
5.46
1.7
1.7
—
—
—
0
0
72
408
1.89
5.44
2.2
3.1
1.90
1.87
%
0.10
66
369
29
113
2.66
5.40
1.2
1.3
1.74
121.51
e6/l
1.31
19
86
204
1561
1.52
4.81
5.5
3.2
27.80
75.45
ng/l
0.59
132
986
119
811
1.61
4.67
1.8
1.6
463.11
45049247.70
pmol/l
1.26
101
717
250
2006
1.49
4.64
2.9
2.5
71.10
75.54
nmol/l
1.54
237
1837
51
273
1.97
4.56
3.0
3.3
7.41
7.42
ph
0.17
46
228
30
130
2.39
4.52
1.6
1.5
237.96
306.82
ug/g
0.79
15
79
26
108
2.48
4.29
1.4
1.2
—
—
—
0
0
176
1333
1.49
4.25
4.3
4.2
7.19
8.98
mg/mmol
0.32
119
824
173
1307
1.49
4.22
3.6
3.5
65.60
49.16
mg/l
0.28
116
834
24
97
2.55
4.19
1.1
1.2
—
—
—
0
0
32
148
2.24
4.18
2.5
1.7
—
—
—
0
0
7
247
0.27
4.13
1.0
1.2
1.00
0.92
g/l
—
7
247
45
241
1.95
4.03
1.2
1.2
—
—
—
0
0
444
4087
1.76
3.97
8.1
5.4
1.68
1.84
mu/l
3.08
427
3855
32
156
2.12
3.70
1.4
2.1
1.38
1.45
g/l
0.16
26
140
165
1275
1.44
3.47
6.5
3.5
0.00
0.01
estimate
0.96
59
457
17
64
2.71
3.43
1.2
1.5
—
—
—
0
0
17
64
2.71
3.43
1.2
1.5
—
—
—
0
0
17
64
2.71
3.43
1.2
1.5
—
—
—
0
0
17
64
2.71
3.43
1.2
1.5
—
—
—
0
0
8
239
0.32
3.41
1.0
1.1
1.69
1.51
g/l
—
8
239
7
226
0.30
3.40
1.0
1.1
—
0.74
—
0
26
36
637
0.53
3.38
1.6
1.5
—
—
—
0
0
51
302
1.77
3.37
1.8
3.3
73.79
75.71
e9/l
0.18
31
210
27
128
2.17
3.36
1.1
1.2
—
—
—
0
0
22
96
2.35
3.31
1.2
1.1
—
—
—
0
0
39
221
1.83
2.99
1.3
1.6
281.80
289.35
mu/l
0.09
30
206
175
1400
1.38
2.93
2.8
2.3
—
—
—
0
0
9
22
4.15
2.89
4.0
2.4
0.67
0.73
index
—
9
22
240
2023
1.36
2.89
2.9
2.7
—
—
estimate
—
0
0
14
53
2.69
2.81
1.3
1.2
—
—
—
0
0
47
290
1.68
2.72
3.3
4.1
4.28
4.64
pmol/l
1.71
41
260
14
55
2.59
2.63
1.1
1.4
—
—
nmol/l
—
0
0
27
143
1.94
2.56
11.8
10.1
—
—
—
0
0
15
322
0.45
2.51
1.7
1.7
—
—
—
0
0
8
21
3.85
2.47
2.7
5.6
18.05
17.96
%
—
8
21
14
57
2.50
2.47
1.2
1.3
0.17
0.17
nmol/l
—
9
43
89
651
1.45
2.45
2.4
2.7
114.78
111.80
ug/g
0.04
70
515
144
1149
1.36
2.39
2.5
2.6
335.28
334.43
umol/l
0.03
127
1038
79
568
1.46
2.38
1.4
1.4
—
—
—
0
0
5
8
6.30
2.37
1.0
1.0
—
—
—
0
0
46
295
1.62
2.32
2.2
2.2
4.22
7.85
ug/l
1.28
40
273
146
1177
1.34
2.25
1.4
1.3
2.59
1.49
u/ml
0.26
42
344
46
300
1.59
2.18
6.1
3.7
1.21
1.23
mmol/l
1.05
38
264
48
317
1.57
2.16
1.3
1.3
21.00
27.27
iu/l
0.90
35
275
8
25
3.23
2.10
1.4
1.3
6.02
6.67
mmol/l
—
8
25
228
1973
1.29
2.06
1.9
1.9
1.57
1.44
mmol/l
1.16
189
1710
141
1148
1.32
2.01
9.0
5.1
—
—
—
0
0
44
291
1.56
1.98
3.4
4.2
79.41
81.91
ng/l
0.05
39
267
18
91
2.01
1.97
1.3
1.1
—
—
—
0
0
56
391
1.49
1.97
8.4
5.9
0.00
0.16
%
1.20
12
96
53
746
0.68
1.96
2.7
2.7
0.38
0.69
ug/l
6.47
38
386
208
1791
1.28
1.92
5.9
3.3
0.02
0.03
estimate
0.15
48
401
12
53
2.30
1.82
1.7
1.7
9.71
11.48
%
0.86
12
53
58
415
1.45
1.82
7.8
5.2
0.83
0.97
%
0.23
18
136
404
4247
0.75
1.74
4.5
4.2
1.53
1.32
mmol/l
5.81
385
3987
7
25
2.82
1.65
1.1
1.4
—
—
—
0
0
7
26
2.72
1.58
1.1
1.4
138.09
150.92
nmol/l
—
7
26
427
4442
0.74
1.57
5.2
4.9
1.34
1.46
mmol/l
9.05
408
4194
28
177
1.62
1.55
1.1
1.3
—
—
—
0
0
26
162
1.64
1.52
1.8
1.8
—
—
—
0
0
454
4370
1.41
1.47
28.4
13.9
24.67
21.50
mg/l
1.42
408
3525
23
361
0.62
1.45
1.5
1.4
—
—
—
0
0
31
205
1.55
1.44
3.7
2.1
279.98
5901.78
u/l
1.56
13
86
28
183
1.56
1.37
1.7
2.1
—
—
—
0
0
0
39
0.00
1.34
0.0
1.3
—
167.23
—
0
39
124
1046
1.25
1.30
1.4
1.4
2.58
2.42
g/l
0.24
68
676
432
4143
1.31
1.29
7.7
5.8
39.02
38.76
mmol/mol
0.21
418
3954
5
18
2.79
1.29
1.4
2.2
0.53
1.11
ug/l
—
5
18
52
393
1.36
1.24
6.7
5.1
1.00
0.65
%
0.25
15
117
51
385
1.36
1.23
1.8
2.8
11.05
10.43
g/l
0.42
43
358
51
389
1.35
1.16
8.7
5.4
0.36
0.15
%
0.48
11
110
5
21
2.39
1.09
1.0
1.6
—
—
—
0
0
15
90
1.69
1.05
1.7
1.9
—
—
—
0
0
5
22
2.29
1.03
1.2
1.4
—
—
—
0
0
14
224
0.61
1.00
1.1
1.1
—
—
—
0
0
7
134
0.52
1.00
1.0
1.3
—
—
—
0
0
51
399
1.31
1.00
2.5
2.1
0.00
0.05
estimate
0.78
13
97
7
36
1.96
0.97
1.1
1.2
—
—
—
0
0
6
27
2.24
0.93
1.0
1.1
1431.83
1730.59
miu/ml
—
6
27
12
70
1.73
0.93
1.7
1.3
—
—
—
0
0
10
55
1.83
0.92
1.8
2.2
—
—
—
0
0
6
28
2.16
0.91
1.7
3.3
984.50
1095.96
mg
—
6
28
18
120
1.52
0.86
1.4
2.4
—
—
—
0
0
8
44
1.83
0.86
3.4
3.2
—
—
—
0
0
437
4242
1.24
0.84
6.7
4.7
6.14
5.87
mmol/l
4.01
426
3971
27
200
1.37
0.78
2.0
3.6
—
—
—
0
0
24
175
1.39
0.76
1.3
1.3
14.74
9.49
u/l
0.65
15
146
13
83
1.58
0.75
1.2
1.3
5.00
7.31
u/ml
—
6
35
15
100
1.52
0.73
1.7
1.4
2570.00
13644.68
e6/l
—
10
68
5
25
2.01
0.73
1.0
2.6
615.00
719.72
u/ml
—
5
25
5
25
2.01
0.73
2.2
5.0
6.86
8.15
mmol/l
—
5
25
5
25
2.01
0.73
1.2
1.4
515.40
2251.31
e6/l
—
5
16
19
262
0.71
0.70
6.1
2.6
28.04
38.99
u/ml
0.43
19
253
435
4451
0.83
0.70
5.5
5.0
4.55
4.77
mmol/l
5.24
418
4226
9
59
1.53
0.68
2.4
2.4
—
—
—
0
0
7
119
0.58
0.68
1.1
1.6
—
—
—
0
0
42
341
1.25
0.66
5.6
3.4
—
—
—
0
0
100
884
1.16
0.66
1.4
1.3
7.48
12.36
u/ml
0.37
36
359
27
347
0.77
0.65
2.9
2.1
6.12
6.11
ph
0.04
20
211
8
130
0.61
0.64
1.3
1.1
—
—
—
0
0
8
130
0.61
0.64
1.3
1.1
—
—
—
0
0
15
104
1.46
0.63
7.5
3.5
55.53
57.72
%
0.23
15
104
8
49
1.64
0.62
1.5
2.2
32.50
32.65
pg
—
8
49
21
156
1.36
0.62
2.1
3.7
24.88
24.82
mmol/l
0.03
21
148
25
322
0.76
0.61
1.2
1.1
—
—
—
0
0
8
50
1.61
0.61
1.0
1.3
—
—
—
0
0
8
50
1.61
0.61
1.1
1.1
—
—
—
0
0
0
20
0.00
0.60
0.0
1.7
—
83.15
—
0
20
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
12
80
1.51
0.60
4.1
3.7
3.22
4.23
e9/l
0.95
12
80
0
21
0.00
0.60
0.0
1.2
—
0.00
—
0
21
62
532
1.19
0.59
2.2
1.8
—
—
—
0
0
7
116
0.60
0.58
1.1
1.4
—
—
—
0
0
11
73
1.52
0.56
1.3
1.1
—
—
—
0
0
60
516
1.18
0.56
1.6
1.4
—
—
—
0
0
41
340
1.22
0.55
1.2
1.2
—
—
—
0
0
38
317
1.22
0.50
1.3
1.7
1.61
1.39
g/l
0.26
32
299
7
46
1.53
0.48
1.0
1.2
—
—
—
0
0
7
47
1.50
0.47
1.6
1.6
17.31
29.41
ng/l
—
7
47
61
535
1.16
0.47
1.5
1.4
—
—
—
0
0
13
94
1.39
0.46
1.9
1.4
16.11
24.76
u/l
0.81
13
80
109
1188
0.89
0.45
3.8
4.2
1.19
1.89
ug/l
1.67
101
1089
234
2227
1.10
0.45
3.7
3.1
96.96
111.51
ug/l
0.71
217
2111
17
130
1.32
0.44
3.5
2.2
3.25
4.26
iu/l
—
8
60
13
95
1.38
0.44
1.8
2.5
25.90
97.21
ug/min
—
6
55
47
407
1.17
0.43
1.1
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
3.7
—
—
—
0
0
20
159
1.27
0.40
1.6
1.2
—
—
—
0
0
0
17
0.00
0.40
0.0
2.3
—
28.00
—
0
17
0
18
0.00
0.40
0.0
4.2
—
82.91
—
0
11
0
18
0.00
0.40
0.0
2.1
—
—
—
0
0
44
382
1.17
0.40
1.1
1.3
58.81
122.51
u/ml
0.96
14
157
5
79
0.63
0.35
5.8
3.6
—
—
—
0
0
14
108
1.30
0.35
1.2
3.7
1.09
1.97
ratio
—
6
64
10
73
1.38
0.34
1.7
1.4
—
—
—
0
0
6
46
1.31
0.33
1.0
1.1
—
—
—
0
0
19
155
1.23
0.33
1.1
1.3
—
—
—
0
0
6
47
1.28
0.32
1.3
1.5
16.50
21.59
nmol/l
—
6
42
11
83
1.33
0.32
1.6
2.6
6.88
7.05
pmol/l
0.03
11
83
168
1762
0.93
0.31
2.0
2.0
—
—
—
0
0
13
161
0.80
0.27
1.5
2.0
129.08
222.41
pmol/l
3.09
13
152
17
204
0.83
0.27
1.4
2.0
39.12
38.56
nmol/l
0.03
17
198
16
193
0.82
0.27
1.1
1.2
—
—
—
0
0
10
77
1.30
0.26
1.1
1.3
—
—
—
0
0
5
74
0.67
0.26
1.2
1.1
—
6.68
—
0
26
20
233
0.85
0.24
2.9
2.2
0.00
0.05
estimate
0.68
12
81
23
199
1.16
0.24
1.7
1.4
101.51
232.23
miu/ml
—
7
98
445
4494
0.91
0.23
6.4
5.5
2.68
2.84
mmol/l
3.96
430
4252
5
39
1.28
0.23
1.0
1.2
—
—
—
0
0
5
39
1.28
0.23
1.2
1.1
—
—
—
0
0
5
42
1.19
0.21
2.4
2.1
34.40
39.63
%
—
5
42
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
1.88
—
0
11
0
11
0.00
0.21
0.0
4.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
1.34
—
0
6
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
12
145
0.82
0.21
1.8
3.0
1.33
1.32
mg/l
0.02
12
132
5
43
1.16
0.21
1.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
459
4552
1.10
0.20
25.3
12.5
—
—
—
0
0
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
386
3810
1.06
0.18
44.7
17.6
331.57
333.17
g/l
2.86
386
3791
7
62
1.13
0.17
2.4
2.6
4.06
4.96
u/ml
—
7
62
5
68
0.73
0.17
2.0
3.7
2.00
1.51
%
—
5
62
8
69
1.16
0.16
1.0
1.9
—
—
—
0
0
27
245
1.11
0.15
1.1
2.5
—
—
—
0
0
6
80
0.75
0.15
1.0
1.1
—
—
—
0
0
15
131
1.15
0.14
3.3
2.4
14.29
11.28
mg/l
0.80
15
124
14
159
0.88
0.13
2.8
1.7
1.23
1.20
g/l
0.10
14
154
75
718
1.05
0.13
1.2
1.4
250.67
571.08
titre
3.69
15
166
5
44
1.14
0.10
2.2
1.8
—
—
—
0
0
12
106
1.14
0.10
1.8
1.4
—
—
—
0
0
5
63
0.79
0.08
1.0
1.2
—
—
—
0
0
54
561
0.96
0.08
1.3
1.2
—
—
—
0
0
98
966
1.02
0.03
1.3
1.3
13.54
30.49
iu/ml
4.50
27
306
16
151
1.06
0.03
3.6
4.1
84.86
225.60
mg/l
—
7
70
464
4649
0.97
0.02
17.9
11.8
27.96
27.90
u/l
0.02
457
4552
22
213
1.03
0.01
1.2
1.2
0.82
2.12
u/ml
—
5
14
135
1342
1.01
0.01
4.1
2.9
0.00
0.02
estimate
1.47
49
385
38
378
1.01
0.00
4.4
4.4
2.70
17.82
ug/l
0.72
32
303
17
171
0.99
0.00
1.8
1.6
—
14.34
—
0
7
129
1295
0.99
0.00
1.3
1.5
—
—
—
0
0
6
69
0.87
0.00
1.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
52.00
—
0
8
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.7
—
70.33
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
67.00
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
6.6
—
5.63
—
0
8
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
57
0.88
-0.00
2.2
2.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
6.52
—
0
9
0
5
0.00
-0.00
0.0
2.2
—
38.20
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
15.06
—
0
5
0
6
0.00
-0.00
0.0
1.8
—
260.67
—
0
6
0
6
0.00
-0.00
0.0
3.3
—
6.90
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
8
85
0.94
-0.00
2.1
2.0
3.99
5.27
mmol/24h
—
8
75
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.4
—
12.40
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_POISO_MEDICI_ADVERSE – Poisoning by medicine, drug-induced

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).